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eIF2The protein kinaseGcn2 is present in virtually all eukaryotes and is of increasing interest due to its involvement in
a large array of crucial biological processes. Some of these are universally conserved from yeast to humans, such
as coping with nutrient starvation and oxidative stress. In mammals, Gcn2 is important for e.g. long-term
memory formation, feeding behaviour and immune system regulation. Gcn2 has been also implicated in diseases
such as cancer and Alzheimer's disease. Studies on Gcn2 have been conductedmost extensively in Saccharomyces
cerevisiae, where the mechanism of its activation by amino acid starvation has been revealed in most detail.
Uncharged tRNAs stimulate Gcn2 which subsequently phosphorylates its substrate, eIF2α, leading to reduced
global protein synthesis and simultaneously to increased translation of speciﬁc mRNAs, e.g. those coding for
Gcn4 in yeast and ATF4 in mammals. Both proteins are transcription factors that regulate the expression of a
myriad of genes, thereby enabling the cell to initiate a survival response to the initial activating cue. Given that
Gcn2 participates in many diverse processes, Gcn2 itself must be tightly controlled. Indeed, Gcn2 is regulated
by a vast network of proteins and RNAs, the list of which is still growing. Deciphering molecular mechanisms
underlying Gcn2 regulation by effectors and inhibitors is fundamental for understanding how the cell keeps
Gcn2 in check ensuring normal organismal function, and how Gcn2-associated diseases may develop or may
be treated. This review provides a critical evaluation of the current knowledge on mechanisms controlling
Gcn2 activation or activity.
© 2014 Published by Elsevier B.V.1. Introduction
The protein kinase Gcn2 was ﬁrst found to be part of a signalling
pathway that enables Saccharomyces cerevisiae to sense and overcome
amino acid deprivation [1–3]. No matter whether the cell is starving
for several or only one amino acid, this signalling pathway is activated,
leading to the reprogramming of the cellular gene expression proﬁle,
which includes increased expression of genes that code for enzymes
in various amino acid biosynthetic pathways. This regulatory module
governed by Gcn2 was therefore called General Amino Acid Control
(GAAC) in S. cerevisiae, or Cross Pathway Control (CPC) in the ﬁlamen-
tous fungi Neurospora and Aspergillus. Mammals contain three kinases
in addition to Gcn2 that phosphorylate the same substrate, the α
subunit of eukaryotic translation initiation factor 2 (eIF2α), each
responding to distinct stimuli: HRI, PKR and PERK(PEK) [1–3] (Fig. 1).
As eIF2α is the common downstream target that integrates signalling
from all eIF2α kinases, in mammals this pathway was termed the
Integrated Stress Response (ISR) [4]. Gcn2 stands for “General controlathematical Sciences, Massey
, Auckland, Albany 0745, New
er).non-derepressible” 2, and in mammals it is also called EIF2AK4
(eukaryotic translation initiation factor 2 alpha kinase 4) [1–3]. The
Gcn2 orthologue in Neurospora and Aspergillus is called Cpc3 and
CpcC, respectively [5,6].
As all eIF2α protein kinases, Gcn2 exerts its function via phosphory-
lating a speciﬁc amino acid in eIF2α (Ser-51 in yeast and mammals)
(Fig. 1) [1–3]. Themolecular basis of Gcn2 function and themechanisms
underlying its activation have been predominantly studied in the yeast
S. cerevisiae [1]. The immediate signal of amino acid starvation is
uncharged tRNAs (tRNAdeacyl) accumulating in the cell. These are
detected by Gcn2, leading to the stimulation of its protein kinase
catalytic domain and subsequent phosphorylation of eIF2α [1]. eIF2 in
a GTP-bound form is essential for initiating protein synthesis in that it
delivers initiator methionyl tRNA (Met-tRNAiMet) to the ribosome.
After completing translation initiation eIF2 is released in its GDP
bound form, and it needs to be recycled to the GTP-bound form by its
guanine nucleotide exchange factor (GEF) eIF2B. Phosphorylation of
eIF2α by Gcn2 converts eIF2 to a competitive inhibitor of eIF2B, leading
to reduced global protein synthesis and thus to reduced overall
utilisation of amino acids (Fig. 1). Simultaneously, eIF2α phosphoryla-
tion evokes increased translation of speciﬁc mRNAs containing in their
5′ leader unique upstream open reading frames (see review [1,7,8]),
such as those coding for Gcn4 in yeast and ATF4 in mammals (Fig. 1).
Fig. 1. In all eukaryotes, from yeast to mammals, phosphorylation of theα subunit of eIF2
is a major mechanism to adjust the cellular gene expression proﬁle in response to speciﬁc
cues. While global protein synthesis is reduced, eIF2α phosphorylation simultaneously
leads to increased translation of mRNAs containing speciﬁc uORFs. These mRNAs code
for transcription factors, e.g.Gcn4 in yeast and ATF4 inmammals, that regulate expression
of a large array of genes. In all eukaryotes, the protein kinase phosphorylating eIF2α in re-
sponse to amino acid starvation is Gcn2 (EIF2AK4; orGcn2-like). Some eukaryotes contain
additional eIF2α kinases, such as PKR, HRI and PEK/PERK in mammals. Heme regulated
Inhibitor (called HRI or EIF2AK1) is activated by heme deprivation in erythroid cells;
RNA-dependent protein kinase (PKR, EIF2AK2) is stimulated by double stranded RNAs
accumulating during viral infections; and PKR-like endoplasmic reticulum kinase (PEK,
PERK, EIF2AK3) is activated by the accumulation of misfolded proteins in the endoplasmic
reticulum. Like Gcn2, these kinases have been found to respond to additional cues, and
some overlap of function may occur [3,31].
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hundreds of genes that promote the recovery of cells from the initial
insult (e.g. [1–4,9–11]). For example, Gcn4/Atf4 induces expression of
genes coding for key amino acid biosynthetic enzymes and amino acid
transporters.
As in yeast,mouseGcn2 is activatedunder lowamino acid availability,
and is required for adaptation to amino acid starvation [12–15]. Although
mice lacking Gcn2 are viable, under amino acid deprivation they display
aberrant protein production in the liver, and enhanced skeletal muscle
loss, and Gcn2−/− mice starved after birth exhibit increased morbidity
in response to amino acid deprivation [16]. Interestingly, feeding on
diets devoid of essential amino acids results in Gcn2-dependent eIF2α
phosphorylation in the anterior piriform cortex, and this is associated
with the development of an aversive behaviour towards the amino-acid
imbalanced food, the latter again being dependent on Gcn2 [17,18].
Notably, it is becoming evident that Gcn2 is implicated in many
other biological processes that are seemingly unrelated to the mainte-
nance of amino acid homeostasis (Table 1). Gcn2 has been associated
with a range of normal physiological responses as well as with diseases
or disorders (Table 1). For example, amino acid catabolising enzymes
are used for signalling purposes, such as the Trp-speciﬁc Indoleamine-
2,3-dioxygenase (IDO) [19]. IDO-expressing cells cause Trp depletion
in the immediate cellular environment to trigger responses from
neighbouring cells, e.g. suppressing T-cell proliferation in a manner
that is dependent on Gcn2 function [20]. Gcn2 controls memory forma-
tion [21]. Cancer cells depend on Gcn2 for survival and proliferation[22]. Treatment of acute lymphoblastic leukemia with asparaginase
(ASNase) is based on thedepletion of serumasparagine, thereby depriv-
ing cancer cells of this amino acid. In mice, studies suggest that inhibi-
tion of Gcn2 may aid in enhancing the efﬁcacy of ASNase and other
anticancer drugs that involve deprivation of amino acids [23]. In plants
(Arabidopsis), Gcn2 was found to respond to wounding, and it is essen-
tial for growth in stress conditions [24,25]. In Caenorhabditis elegans, hy-
pertonic stress activates Gcn2, and the subsequent reduced protein
synthesis is crucial for survival [26]. Also in C. elegans, Gcn2 affects the
life span under dietary restricting conditions [27]. In the obligatory in-
tracellular parasite Toxoplasma gondii, a Gcn2-like kinase promotes the
survival of the parasite upon egress from the host cells [28]. Gcn2 may
be involved in development, as knock-down of Gcn2 in Drosophila em-
bryos inhibits larval development [29]. Differential expression of Gcn2
may also account for some of its biological effects. For example, several
tumours have been identiﬁed with augmented levels of this kinase
(total and active forms) relative to neighbouring normal cells [22].
Gcn2 is also present in high amounts in mouse oocytes [30]. Reports
are constantly emerging on new biological roles for Gcn2. These have
been the focus of several recent reviews (e.g. [3,31–37]), and examples
for Gcn2 roles are summarised in Table 1.
Given that Gcn2 activation leads to a dramatic change in the cellular
gene expression proﬁle, tight regulation of Gcn2 activity is paramount
to the cell and the organism. Several molecules have been reported
that modulate Gcn2 function, and additional proteins have been found
that again control Gcn2-regulatory proteins, and the list is still growing,
suggesting that cells harbour a complex network that keeps Gcn2 in
check (Fig. 2). Many of the Gcn2 regulators are highly conserved, from
yeast to mammals. This is not surprising given that Gcn2 is implicated
in many ubiquitous and fundamental biological functions. However,
some Gcn2 regulators may have evolved to control Gcn2 in speciﬁc
cells or under speciﬁc conditions. This review aims to give a comprehen-
sive overview of the knowledge gained so far about molecules and
molecular mechanisms regulating Gcn2 activity or activation.
2. Gcn2 domain composition and properties
The Gcn2 protein is composed of (from the N- to the C-terminus) an
N-terminal RWD-domain (from its presence in RING ﬁnger proteins,
WD-repeat-containing proteins, and yeast DEAD-like helicases), a
pseudokinase domainwith no enzymatic function, the eIF2α kinase cat-
alytic domain, a domain with similarity to histidyl-tRNA synthetases
(HisRS-like, is enzymatically inactive) that together with the C-
terminus binds tRNAsdeacyl, and a C-terminal dimerisation and ribosome
binding domain (CTD) [1] (Fig. 3). Adjacent to the RWD domain is a
highly charged region [38]. Biochemical and genetic studies suggest
that Gcn2 forms dimers or tetramers, and that dimerisation is mediated
by a concerted action of the kinase domain, HisRS-like domain, and the
CTD (Fig. 3) [39–41]. The latter is more critical for dimerisation in vivo
[42]. Just recently, the crystal structures of yeast and mouse Gcn2 CTD
dimers have been resolved, revealing structural similarities and differ-
ences, while their functions seem to be similar [253]. As found for
yeast Gcn2, studies suggest that mouse Gcn2 function requires
dimerisation of the CTD [42,253].
Gcn2 is held in its inactive state via several auto-inhibitorymolecular
interactions, ensuring that it remains in a latent state until exposed to an
activating signal [40,41,43–45] (Fig. 3). Binding of tRNAdeacyl to the
HisRS-like and CTD domain results in allosteric re-arrangements. This
leads to Gcn2 auto-phosphorylation at speciﬁc amino acids in the
activation loop of the protein kinase domain (Thr-882 and Thr-887 in
S. cerevisiae, and the corresponding Thr-898 and Thr-903 in mouse
Gcn2) [13,15,46,47], to then allow Gcn2 to efﬁciently phosphorylate
its substrate, eIF2α [41,43,44,48,49] (Fig. 3).
Based on common denominators in the structure of the kinase
domain of PKR, and the crystal structures of the kinase domain of in-
active and constitutively active Gcn2, and on the phenotypes of several
Table 1
Gcn2 is involved in a large array of biological functions not directly related to overcoming nutrient starvation. Listed are examples of Gcn2 implications in organismal functions, diseases,
disorders and pathogenicity.
Organism and function References
Human/mouse
Metabolism Regulates liver lipid metabolism [222,223]
Regulates liver gluconeogenesis [224]
Determines age-related macronutrient preference [225]
Increases insulin sensitivity in dietary restriction [226]
Immune system Promotes innate immunity [227,228]
Regulates T cell differentiation and proliferation [20,203,229]
Protects from autoimmune encephalomyelitis (disease model for multiple sclerosis) [230]
Promotes yellow fever vaccine efﬁcacy [228]
Neurobiology Required for memory formation [21]
Regulates feeding behavior towards amino acid source [17,18]
Protects brain from lethal leukodystrophy in amino acid deﬁciency [231]
Contributes to neuronal dysfunction in Alzheimer's disease [232]
Cancer Promotes tumor angiogenesis and tumour growth [22,233]
Mitigates toxicity of asparaginase anti-cancer treatment [23]
Viral infections Host resistance to infection by RNA and DNA viruses [96,184,186]
Other Loss-of-function mutations cause familial pulmonary veno-occlusive disease [234]
Mediates dietary restriction induced protection from surgical stress [235]
Impairs adaptative responses to congestive heart failure [236]
Directs autophagy in response to different stress arrangements [237–239]
Contributes to redox homeostasis [240]
Protects renal cells from high urea concentrations [241]
Contributes to cell cycle arrest in response to hypoxia [242]
Other organisms
S. cerevisiae Regulates life span [243]
Regulates a G1/S cell cycle checkpoint in response to DNA damage [244]
S. pombe Regulates a G1/S cell cycle checkpoint in response to UV irradiation [245,246]
C. elegans Regulates life span [27]
D. discoideum Regulates developmental programs [144,247].
Drosophila Confers susceptibility to bacterial infection [248]
Arabidopsis Confers resistance to herbicides [249]
Confers resistance to stresses, e.g., cold shock, wounding [24]
Parasites Promotes extracellular viability of Toxoplasma gondii [28]
Fig. 2. Gcn2 activity is tightly controlled by a complex network of molecules that directly bind and regulate Gcn2, or that regulate Gcn2 indirectly by interacting with Gcn2-binding
proteins, or that control Gcn2 via yet unknown mechanisms. For more see text.
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Fig. 3. Schematic representation of the domain arrangement in yeast Gcn2 (blue). From the N- to the C-terminus Gcn2 is composed of the RWD, pseudokinase (ΨPK), protein kinase (PK),
HisRS-like, and C-terminal (CTD) domains. Next to the RWD domain is a highly charged region (+/−). Coloured double arrows above Gcn2 indicate areas that are sufﬁcient for binding to
Gcn1 [62], Hsp90 [205], tRNA [69], eEF1A [153] and ribosome [70]. Shown belowGcn2 are regions involved in intermolecular Gcn2 dimerisation, each region interactingwith the identical
region of a second Gcn2 molecule [41]. Areas involved in heteromeric interactions are indicated by grey double arrows [40,41]. Amino acid residues in Gcn2 with known function
are shown, such as Ser-577 which reduces Gcn2 afﬁnity to tRNAdeacyl when phosphorylated by an unknown kinase [197]. Its dephosphorylation is regulated by the TOR pathway [88].
Lys-628 is crucial for the kinase catalytic activity [60]. Thr-882 and Thr-887 are auto-phosphorylation sites required for Gcn2 activation [46]. Tyr-1119 and Arg-1120 in the m2 motif of
the HisRS-like domain are required or tRNA binding [67]. Lys-1552, Lys1553, and Lys-1556 are required for ribosome association and to some extent for tRNAdeacyl binding [69,70]. The
Gcn2 N-terminal 69 amino acids were uncovered around 1999, and any information on amino acid numbers taken from papers published before that year was adjusted accordingly.
1951B.A. Castilho et al. / Biochimica et Biophysica Acta 1843 (2014) 1948–1968mutants, it was found that in addition to auto-inhibitory interdomain
interactions, mechanisms intrinsic to the kinase domain keep Gcn2 in
its latent form. Within the kinase domain, the catalytic site is located
in a cleft between the N- and C-terminal lobes that are connected by a
hinge region. In the inactive state, hinge rigidity, a closed conformation
of the lobes, distorted conformation of amino acid residues necessary
for e.g. binding the ATP triphosphate moiety, and a ﬂap located over
the ATP binding pocket, prevent ATP and eIF2α binding and catalysis.
Activation of the kinase is achieved by the re-arrangement of inter-
actions between speciﬁc amino acid residues. Thereby, the hinge region
loses its rigidity to allow inter-lobe ﬂexibility and widening of the
catalytic cleft, proper positioning of key residues, and removal of
the ‘gatekeeper’ ﬂap. ATP entering the catalytic site allows auto-
phosphorylation of Gcn2 to then ‘lock’ it into its open active state. For
more details on the proposed mechanism of Gcn2 autoinhibition and
activation upon tRNAdeacyl binding we refer to [41,43–45,48,49].
Upon kinase activation, substrate binding is allowed. The structure
of eIF2α bound to PKR, and mutational and kinetic studies, revealed
that phosphorylation of eIF2α is dependent on a conformational change
of the region encompassing eIF2α Ser-51 which in the isolated protein
is buried in a hydrophobic pocket [50,51]. A model is proposed in
which upon binding to the kinase, an induced ﬁt mechanism leads to
the unfolding of the region carrying Ser-51, thereby exposing Ser-51
and allowing this phospho-acceptor to sufﬁciently project into the
active site of the kinase. This mechanism ensures that Ser-51 in eIF2α
is not phosphorylated by other kinases in vivo [50,51].
Substrate recognition by Gcn2, as well as by the other eIF2α kinases, is
exquisitely dependent on residues far from the Ser-51 phosphorylation
site, as indicated by extensive mutational studies, as well as by the
structural determination of PKR-bound eIF2α [50,52]. Protein database
searches revealed that only eIF2α (and its viralmimetics—Section11)pos-
sesses these required amino acids to accommodate the appropriate folding
for binding to eIF2α kinases [50,52]. It should be noted that, in vitro, PKR
and HRI, and likely all eIF2α kinases, can phosphorylate other substrates,
for example histone and an eIF2α peptide containing Ser-51, however
with very low efﬁciency compared with intact eIF2α [53–55].
The pseudokinase domain is required in vivo [56] and in vitro [57] for
Gcn2 kinase activity. This domain shows sequence similarity tomultiple
subdomains of eukaryotic Ser/Thr protein kinases but residues criticalfor enzyme function are lacking [57,58]. It was proposed that
pseudokinase domains have a regulatory function by directly binding
to the functional kinase domain [59]. The Gcn2 pseudokinase domain
interacts with the kinase domain, raising the possibility that this inter-
action contributes to inhibiting the catalytic activity of the kinase do-
main under non-starvation conditions [40]. Furthermore, mutational
studies suggest that the pseudokinase domain has a stimulatory role
under amino acid starvation conditions [60].
Gcn2, through its RWD domain, must directly bind to its effector
protein Gcn1 to sense amino acid starvation in vivo [61]. The minimal
region in Gcn2 sufﬁcient for Gcn1 binding encompasses amino
acids 1–125 [62]. An independent study showed that Gcn1 binds to
Gcn21–272 in vitro, but not to Gcn21–110 (Gcn21–110 lacks amino acid(s)
proposed to contact Gcn1 [38,63,64]). Together with the fact that
in vivo Gcn2 areas 10–109 and 110–235 are equally required for Gcn1
binding [38], this suggests that Gcn2 harbours Gcn1 binding activities
upstream and downstream of amino acid 110.
The RWD domain of Gcn2 is related to the ubiquitin-conjugating
enzymes (UBC) domain, forming the clade of Ubiquitin-conjugating
enzyme/RWD-like domain (InterPro IPR016135, [65]), predicted to
have a function in protein–protein interaction [66]. RWD domains
including the Gcn2 RWD domain, however, lack the catalytic cysteine
residue critical for ubiquitin-conjugating activity [66]. The structure of
the GCN2 RWD domain has been solved by NMR [63]. The invariant
motif YPxxx(x)P forms a triple β-turn that is unique to the RWD, UBC,
and the Ubiquitin E2 variants (UEV). These residues maintain an inter-
nal hydrogen bond network shown to be essential for the structural
conformation of this domain [63]). Discriminating the RWD domain
from UEV and UBC is the helix α2, also found in Gcn2 [63]. Instead of
this helix the UBC and UEV contain a long extended stretch of residues,
which in UBC encompasses the catalytic Cys residue.
3. tRNAs
Northwestern assays showed that theGcn2HisRS-like domain inter-
acts with tRNAsdeacyl [67]. Class II synthetases, including histidyl-tRNA
synthetases, contain a so-called motif 2 that is involved in binding the
tRNA acceptor stem [68]. Residue substitutions in motif 2 of the
HisRS-like domain (m2 mutation, Y1119L;R1120L) severely reduce
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not or hardly phosphorylate eIF2α in vivo or in vitro, providing the
ﬁrst evidence that tRNA binding to Gcn2 leads to Gcn2 activation [57,
67]. Supporting the idea that increased pools of tRNAdeacyl trigger
Gcn2 activation in vivo, a temperature sensitive mutation in the
HisRS gene, hts1-1, which reduces the levels of charged tRNAHis under
semipermissive conditions, leads to Gcn2 stimulation [67].
Gel shift experiments suggest that puriﬁed Gcn2 preferentially binds
any tRNAdeacyl, rather than amino acylated tRNAs [69]. These studies
also showed that for binding tRNAsdeacyl with high afﬁnity, both the
HisRS and the CTD are necessary and sufﬁcient [69]. Three highly con-
served Lysine residues located in a predicted amphipathic α-helix in
the CTD and known to be involved in ribosome binding (K1552,
K1553, K1556; Section 5), were shown to be essential for tRNAdeacyl
binding, as well as for Gcn2 activation in response the amino acid star-
vation [69,70]. This suggests that Gcn2 contains a second tRNA binding
site, located in the CTD, and/or that the CTD promotes dimerisation of
the HisRS-like region which may be required for tRNAdeacyl binding
[41,69,71]. Supporting the latter, dimerisation of the N-terminal part
of the HisRS-like domain is required for tRNA binding, while tRNA
binding is not required for dimerisation [41]. Importantly, studies
suggest that tRNAdeacyl interacting with the bipartite binding module
in Gcn2 neutralises the autoinhibitory interaction between the protein
kinase domain and the CTD [41,69]. This would be in agreement
with a model in which tRNAdeacyl binding to Gcn2 contributes to its
stimulation.
A sophisticated microarray-based approach for measuring genome-
wide changes in tRNA charging in the cell provided in vivo support for
the idea that any type of tRNAdeacyl contributes to stimulating Gcn2
[72]. This method revealed that in S. cerevisiae the level of Gcn2 activa-
tion by amino acid starvation is directly correlated with the levels of
cognate tRNAsdeacyl. Interestingly, in auxotrophic strains starved for an
essential amino acid, in addition to the increase in cognate tRNAsdeacyl,
other tRNAs become deacylated, even though the cellular levels of
these non-starved amino acids do not decrease. Thus, mechanisms
other than reduced amino acid availability can lead to deacylation of
non-cognate tRNAs [72]. Contributors to this phenomenon may be the
interconnection between synthesis and catabolism of certain amino
acids, compartmentalisation of amino acids and/or tRNAs, tRNA synthe-
tases inﬂuencing each other's activities, alteration in the activity of
trans-editing proteins that can deacylate tRNAs, or the susceptibility of
less abundant tRNAs to deacylation [72].
Themechanismof tRNAdeacyl-mediated Gcn2 activation is conserved
in other organisms. For example, Arabidopsis Gcn2 was shown to bind
tRNAsdeacyl and to phosphorylate Arabidopsis eIF2α [73]. Inmice, inhibi-
tion of tRNA aminoacylation by administering alcohol derivatives of
amino acids directly into the anterior piriform cortex results in Gcn2-
dependent increased eIF2α phosphorylation in the same brain area
[18]. Halofuginone, a component of ancient Chinese medicine used to
ameliorate inﬂammatory phenotypes, inhibits prolil-tRNA synthetase
activity, and this correlates with Gcn2 activation [74,75]. Treatment
of mammalian cells with borrelidin, a macrolide that inhibits the
threonyl-tRNA synthetase, leads to Gcn2 activation [76].
Many other conditions that seem at ﬁrst to be unrelated to amino
acid starvation result in Gcn2 activation in vivo. However, for numerous
of these stress arrangements there is evidence that the ﬁnal signal does
seem to be the accumulation of tRNAsdeacyl. These include starvation for
nutrients other than amino acids. In yeast, glucose starvation triggers
Gcn2 activation that is dependent on the m2 motif in the HisRS-like
domain, indicating that Gcn2 must bind tRNAsdeacyl for activation. It
was suggested that usage of amino acids as alternative carbon source,
and/or as secondary energy source, results in amino acid shortage. In
line with this idea, a decrease in the cytoplasmic pool of amino acids
was observed upon glucose starvation, consistent with the idea that
accumulation of tRNAsdeacyl stimulates Gcn2 [77]. Activation of yeast
Gcn2 by purine starvation may be related to extensive modiﬁcationsthat occur in tRNAs [78]. For example, it has been shown that the
post-transcriptional addition of a guanine residue to the 5′ end of
tRNAHis is required for its aminoacylation, and depletion of the corre-
sponding modifying enzyme has been shown to activate GAAC in a
Gcn2-dependent fashion [79]. Hence, the low availability of purines
may increase the pool of non-chargable tRNAsHis that stimulate Gcn2.
Of course, other mechanisms cannot be excluded, such as reduced
adenine availability leading to reduced ATP levels, that would impair
amino acylation [78].
Stress regimens other than starvation also appear to involve
tRNAdeacyl for stimulating Gcn2. For example, acidic stress conditions
in yeast results in accumulation of uncharged tRNAsLeu even though
the intracellular Leu pool is not depleted [80]. It was suggested that
this is due to the inhibition of the aminoacyl-tRNA synthetase. High
salinity leads to a transient increase in tRNAsdeacyl [72]. Activation of
Gcn2 by boron treatment requires motif 2 in the HisRS-like domain,
and boron inhibits charging of tRNASer and tRNAPhe by rabbit reticulo-
cyte synthetases [81].
In mammals, UV-irradiation leads to Gcn2 activation [82]. Since no
evidence was found for tRNA deacylation in UV-irradiated mammalian
cells, the authors suggested that UV-light mediated crosslinking of
tRNAs to Gcn2 may activate Gcn2. Studies by others suggest that Gcn2
activation by UV in mammalian cells may stem from the rapid con-
sumption of Arg to produce nitric oxide, a process catalyzed by nitric
oxide synthase (NOS) [83]. Interestingly, in mammals methionyl-tRNA
synthetase (MRS) was reported to be a substrate of UV irradiation-
stimulated Gcn2 [84]. Gcn2 appears to phosphorylate Ser-662 in
MRS's tRNA binding domain. Those studies suggested that Ser-662
phosphorylation reduces tRNAMet binding to MRS, and as expected,
UV irradiation decreases the levels of charged Met-tRNAMet in vivo and
reduces global protein synthesis.
Intracellular events seemingly unrelated to tRNA charging appear to
lead to Gcn2 activation. Methylglyoxal, an endogenous metabolite de-
rived from glycolysis that in high concentrations is deleterious to the
cell, activates Gcn2. No increase in the levels of uncharged tRNAMet
was detected. It remains to be determined whether this compound
increases the levels of other tRNAsdeacyl [85–87]. Rapamycin, a drug
that inhibits the kinase Tor, activates Gcn2 but no increasewas observed
in the two speciﬁc uncharged tRNAs studied (tRNAHis and tRNAMet)
[87–89]. However, it is possible that the charging of other tRNAs may
be affected. Supporting this idea, cells grown on the poor nitrogen
source γ-aminobutyric acid, which deactivates the Tor signaling
pathway, show increased levels of uncharged tRNACys and tRNAPhe
[11]. Apart from that, rapamycin-mediated Tor inhibition increases the
afﬁnity of Gcn2 for tRNAdeacyl [88] (see Section 12).
Other intracellular events may impair tRNA charging by affecting
amino acid supply. For example, invasion of host cells by pathogenic
bacteria (Shigella, Salmonella, Listeria) triggers Gcn2 activation, and
this was associated with decreased levels of cellular amino acids due
to membrane leakage [90,91]. In yeast, deletion of GCN1 or GCN2
renders cells sensitive to the tubulin depolymerizing agent benomyl,
indicating that microtubule disassembly leads to Gcn2 activation [92].
Considering that tubulin is involved in various processes in the cell
such as in intracellular transport [93], benomyl may affect, directly or
indirectly, the intracellular localisation of amino acids, tRNAs, or tRNA
synthetases, or the trafﬁcking of amino acid transporters (especially
considering that strains used in this experiment have amino acid
auxotrophies). Thus, tubulin depolymerisation may impair the efﬁcien-
cy of tRNA charging.
Activation of Gcn2 by proteasome inhibition [94] appears to be due
to the intracellular reduction of the free amino acid pool, in yeast and
mammalian cells [95]. In S. cerevisiae, the genetic impairment of protea-
some function by using the thermo-sensitive regulatory subunit Rpt6
(cim3-1 mutant) results in decreased free pools of most amino acids,
blocking protein synthesis and leading to lethality even in richmedium.
Addition of all amino acids to the richmedium rescues protein synthesis
Table 2
Components required for Gcn2 activation in response to speciﬁc activating signals in Saccharomyces cerevisiae. For each cue is listed the phenotype conferred by Gcn2 (comparing the
growth behaviour between a wild-type and gcn2Δ strain), whether Gcn2 activation requires Gcn2 dimerisation, Gcn2–ribosome interaction, the presence of Gcn1 or Gcn20, whether
the cue leads to increased tRNAsdeacyl levels, whether the Gcn2 m2 sequence is required, and whether increased eIF2α phosphorylation (eIF2α-P) was observed. The activating cues
are amino acid starvation, 8-azaadenine (purine starvation), Saline stress (excess NaCl), glucose starvation, H2O2 (oxidative stress), Acetic acid (acidic stress), Boron, Methyl Glyoxal,
Rapamycin, Tunicamycin, Methyl methanesulfonate (DNA damage), Hydoxyurea, Heterologous gene expression, Benomyl (Microtubule depolymerisation), Methionine-S-sulfoximine
(Gln/Nitrogen starvation). (−) No phenotype was found or reported.
Stress Phenotype Gcn2
dimerisation
Gcn2–ribosome
binding
Gcn1
required
Gcn20
required
tRNAsdeacyl
increased
Gcn2 m2
required
increased
eIF2α-P
reference
Amino acid starvation Resistance Yes Yes Yes Yes Yes Yes Yes See text
8-azaadenine Resistance Yes Yes [78]
Yes Yes Yes Yes [77]
Excess NaCl Sensitivity Yes Yes Yes [250]
Yes Yes Yes Yes Yes [42]
Yes Yes [72]
Glucose starvation – Yes Partially Yes Partially Yes Yes [77]
H2O2 Resistance Yes Yes [251]
Acetic acid Resistance Yes Partially Yes Yes [80]
Boron Resistance Yes Yes Yes [81]
Methyl Glyoxal Resistance Yes Yes [86]
Yes No (tRNAMet) Yes [87]
Rapamycin Sensitivity Yes Yes [88]
Yes No (tRNAHis) Yes Yes [89]
Yes Yes Yes Yes Yes [42]
After 30 min No (tRNAMet) Yes [87]
Tunicamycin – Yes [88]
Methyl methanesulfonate – Yes Yes Yes [10]
Yes [88]
Hydoxyurea – Yes [88]
Heterologous gene expr. – Yes Yes Yes Yes [252]
Benomyl Resistance Yes [92]
Methionine-S-sulfoximine Resistance Yes [165]
Yes [92]
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logical inhibition of proteasome activity by MG132 or Bortezomib
causes decreased levels of free cysteine, asparagine and aspartate, and
Gcn2 activation. Again, the addition of these amino acids to themedium
reduces Gcn2 activation and rescues cells from death induced by MG-
132. Thus, blocking proteasome function results in tRNAsdeacyl accumu-
lation due to the lowered pool of cytoplasmic free amino acids, leading
to Gcn2 activation [95].
Although for many stress conditions the levels of tRNAsdeacyl were
not studied, the observations that the ensuing Gcn2 activity was depen-
dent on the m2 sequence in the Gcn2 HisRS-like domain suggest that
tRNAdeacyl is the direct activating signal (Table 2). However, one cannot
exclude the possibility that Gcn2 requires co-activating ligands in addi-
tion to tRNAdeacyl, or that the m2 sequence is required for recognizing
signals other than tRNAdeacyl, directly or indirectly. For example, some
viral RNAs seem to promote Gcn2 activation in lieu of tRNAsdeacyl, as
described in Section 11 [96].
In summary, for most situations that result in Gcn2 activation, the
levels of tRNAsdeacyl are increased. Thus, any interference with the
tRNA charging pathway should modulate Gcn2 activity. In this regard,
it is interesting that mutations in the catalytic domain of several tRNA
synthetases have been identiﬁed in human pathologies [97]. It is tempt-
ing to speculate that the severity of these diseases may be due in part to
increased levels of ATF4 as a result of Gcn2 activation.
4. Ribosomes
Activation of Gcn2 in vivo requires its association with ribosomes as
determined by studies in yeast [98]. Gcn2 is loosely associated with
ribosomes rather than an integral component, and it appears to be in a
dynamic equilibrium between its free and ribosome bound forms [98].
The majority of Gcn2 co-migrates with 80S ribosomes (monosomes)
and with ribosomes actively engaged in translation (polysomes) in co-
sedimentation assays using sucrose gradients, where Gcn2 was identi-
ﬁed by its in vitro auto-phosphorylation activity (the kinase activityseemed to accurately measure the steady-state protein levels [70]).
Co-migration assays using both native gel electrophoresis and sucrose
gradients indicated that Gcn2 has strong afﬁnity for the 60S subunit
but not for 40S [98]. Under conditions that result in the accumulation
of pre-initiation complexes (43S–48S), Gcn2 appears to also associate
with these complexes, raising the possibility that this would facilitate
a direct access to its substrate, eIF2α. Gcn2 kinase activity, its ability to
bind tRNAsdeacyl, and the dimerisation activity in the CTD, are not neces-
sary for Gcn2–ribosome association [42,70].
The Gcn2 CTD (amino acids 1536–1659) is sufﬁcient and essential
for binding to the 60S subunit and for polysome association, and neces-
sary for overcoming amino acid starvation [56,70,98]. However, dele-
tions of other parts in Gcn2 reduce Gcn2–ribosome co-migration to a
small extent (N-terminus, portions of the HisRS-like domain), indicat-
ing that Gcn2 may have additional (weak) ribosome binding sites, or
that Gcn2–ribosome association may be strengthened by other mole-
cules that bind to ribosomes, e.g. Gcn1 [98].
Does Gcn2–ribosome interaction change upon sensing amino acid
starvation? The three highly conserved Lys residues in the Gcn2 CTD
(K1552, K1553, K1556) required for tRNAdeacyl binding are also essential
for strong polysome and 60S association as determined by co-migration
on sucrose gradients [69,70]. Under conditions that dissociate poly-
somes andmonosomes into 40S and 60S subunits, however, the Lys res-
idues are not absolutely required for Gcn2–60S association, but deletion
of 20 amino acids encompassing these Lys residues nearly abolishes this
interaction [69]. This raises the possibility that Gcn2 may utilise differ-
ent subsets of binding determinants in the CTD for association either
to translating ribosomes or to subunits. The observation that the Lys res-
idues are required not only for ribosome-binding, but also for tRNA-
binding, may indicate that these are mutually exclusive interactions
[69,70]. If that is the case, then Gcn2 would dissociate off the ribosome
upon tRNAdeacyl detection. Arguing against this scenario, other studies
suggest that amino acid starvation does not signiﬁcantly affect the
steady-state ribosome-association of Gcn2, Gcn1 or Gcn20, or Gcn1–
Gcn2 interaction [38,98,99]. Shedding light on this aspect is critical for
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cially considering that the above assays are steady-statemeasurements.
The fact that ribosomal association is required for Gcn2 activation
in vivo under amino acid deprivation supports the idea that Gcn2 does
not simply monitor the cytoplasmic tRNAdeacyl levels. Instead, it has
been proposed ﬁrst by Ramirez et al. [98] that a mechanism is in place
that directs ribosomal A-site associated tRNAsdeacyl to Gcn2 for their
detection. This ﬁnds precedent in bacteria, where tRNAdeacyl binding
to the ribosomal A-site during amino acid starvation triggers the strin-
gent response mediated by the RelA protein (see Section 7). Recently
it was reported that acidic ribosomal proteins, in their non-ribosomal
bound form, are required for Gcn2 activation under glucose starvation
or high salinity stress (excess NaCl), but not amino acid starvation
[100]. It remains to be veriﬁed whether these acidic proteins promote
Gcn2 activation directly. Mapping the Gcn2-binding site on the ribo-
some will bring clues about the mechanism by which tRNAs are trans-
ferred to the Gcn2 HisRS-like domain to stimulate the adjacent kinase
domain. Even though mouse Gcn2 appears to not associate with ribo-
somes as strongly as yeast Gcn2, this association may be sufﬁcient for
sensing the A-site associated tRNAdeacyl [253].
5. Gcn1 and Gcn20
Gcn1 was the ﬁrst protein found to promote Gcn2 function. A yeast
strain deleted for the Gcn1 coding gene (gcn1Δ strain) is unable to acti-
vate Gcn2 upon amino acid starvation. Gcn2 kinase activity however,
can be detected in the whole cell extract of a gcn1Δ strain, suggesting
that Gcn1 is not required for the kinase activity per se, but for in vivo ac-
tivation of Gcn2 in response to amino acid starvation [101]. Interesting-
ly, mutations rendering Gcn2 constitutively active (Gcn2c) still require
Gcn1, with the exception of one Gcn2c allele that simultaneously does
not require tRNAsdeacyl for its constitutive activity [49,102]. All in vivo
data in yeast support the idea that Gcn1 is absolutely required for
Gcn2 to detect tRNAsdeacyl.
Gcn1 is a 2672 amino acids long protein and its middle portion
(amino acids 1330–1641) has homology to the N-terminal HEAT repeat
domain of fungal translation elongation factor 3 (eEF3) (Fig. 4) [101].
Some homology to eEF3 can be still detected beyond residue 1641.
HEAT stands for the repeats ﬁrst found in the proteins Huntingtin,
eEF3, protein phosphatase 2 A, and Tor [103]. eEF3 is an ATPase that
binds to ribosomes near the E-site, and studies suggest that its function
is to promote the release of tRNAsdeacyl from the E-site [104–106].
Except of the eEF3 similarity, Gcn1 has no signiﬁcant homologies to
any other protein [101].
In vitro and in vivo binding assays conducted by two independent
research groups revealed that Gcn1 binds to the Gcn2 RWD domain
[38,62], in particular the interaction is mediated by a region in Gcn1
encompassing amino acids 2052–2428 [61] or 2048–2383 [62]. Over-
expression of the Gcn2 RWD domain or the Gcn12052–2428 fragment
impaired cell growth under starvation conditions [38,61,62], and this
was associatedwith reduced eIF2α phosphorylation [38,61], suggesting
that Gcn1–Gcn2 interaction through these regions is required for Gcn2
activation. Compelling evidence for Gcn2 function depending on a direct
Gcn1–Gcn2 interaction was provided by the amino acid substitution at
Arg-2259 in Gcn1 by an alanine residue [61]. R2259A substitution in
full length Gcn1 abolishes Gcn2 activation, and this can be reverted by
overexpressing Gcn2. Arg-2259 is essential for Gcn2 binding in vivo
and for direct Gcn2 binding in vitro, but not for binding to other
known Gcn1 partners in vivo, such as Gcn20 or ribosomes [61]. Further-
more, the impairment of Gcn2 function in vivo by overexpression of
Gcn12052–2428 is dependent on Arg-2259. Mutations in charged amino
acids located in near proximity to Arg-2259 have no effect on Gcn2–
Gcn1 interaction, in vivo or in in vitro. Additional Gcn1 mutations were
found that impair Gcn1–Gcn2 interaction as judged by yeast 2-hybrid
assays, all located C-terminal to R2259 (residues 2280–2370), and
the F2291L substitution was shown to lead to reduced eIF2αphosphorylation [107]. The effect of this mutation on other Gcn1 func-
tions has not been analysed yet, but most likely these are not affected.
Gcn1 may contain additional Gcn2 binding sites. For example, Gcn1
proteins lacking either one of its termini (residues 4–671 or 2476–
2672) seem to have reduced Gcn2 afﬁnity in vivo as judged in co-
precipitation assays [61]. In vivo, Gcn2 activation is impaired if cells
harbour one or the other Gcn1-truncation protein, and this can be
rescued by Gcn2 overexpression, in contrast to a Gcn1 protein lacking
residues 2052–2428. This suggests that 2052–2428 harbour the major
Gcn2 binding determinant, while the others are minor as Gcn2 function
can be rescued by driving the interaction with Gcn2 overexpression and
thus via mass action [61]. It needs to be taken into consideration that
the N-terminal deletion also affects Gcn1–ribosome interaction. Howev-
er, a puriﬁed Gcn1 fragment encompassing the N-terminal 992 amino
acids co-precipitates Gcn2 from whole cell extract derived from a gcn1Δ
yeast strain. Conversely, apart from its RWD domain, Gcn2 may contain
an additional Gcn1 binding site, because in vitro a GST-tagged Gcn2
fragment encompassing only the HisRS-like domain appears to co-
precipitate more Gcn1 (and more of the Gcn1 binding protein Gcn20)
than GST alone [38]. It remains to be determined whether these ‘minor’
interactions are direct or mediated by another molecule or the ribosome.
Gcn1 interacts with translating ribosomes through the region com-
prised of amino acids 1–2052, thus involving the majority of the Gcn1
protein [61] (Fig. 4). Mutations in physically distinct areas within this
region, called M7 and M1, reduce Gcn1–ribosome association, but not
Gcn1–Gcn20 interaction, and this is associated with impaired Gcn2 ac-
tivation under amino acid starvation conditions, suggesting that
Gcn1–ribosome interaction is required for promoting Gcn2 activation
[108]. Area M1, constituting the amino acid sequence ExxWRTKR, is lo-
cated in the eEF3-like region, while area M7, 12 basic residues in a 42
residue stretch, is N-terminal to the eEF3-like region (Fig. 4). The N-
terminal HEAT repeat domain of eEF3 binds to the 40S subunit [105,
109], and the similarity of Gcn1 with the eEF3 HEAT repeat domain
raises the possibility that Gcn1 may also bind to the 40S subunit.
Interestingly, Gcn1 overexpression leads to a growth defect and in-
creased Gcn1–ribosome interaction, implying that an essential cellular
function is affected such as protein synthesis [61]. Gcn1 overexpression
also leads to sensitivity to the drug paromomycin, while strains lacking
Gcn1 are resistant to paromomycin as compared to the wild-type con-
trol. Together with the fact that the ribosome binding property of Gcn1
truncation proteins correlates with paromomycin sensitivity [61], this
indicates that Gcn1 elicits paromomycin sensitivity while bound to the
ribosome. As paromomycin is known to increase the error rate of
translation by interfering with the anticodon recognition of the tRNA
in the A-site [110], these observations suggest that Gcn1 binds close to
the A-site or is able to affect A-site function, directly or indirectly.
In keeping with the essential nature of Gcn1 for Gcn2 function, in
yeast Gcn1 seems to be required in all stress arrangements that activate
Gcn2 (Table 2). Gcn1 Arg-2259 found in S. cerevisiae to be speciﬁcally
required for Gcn1–Gcn2 interaction and Gcn2 activation, and the
amino acids immediately neighbouring this residue, are highly
conserved, conforming to the consensus sequence ITGPLIR[bulky
hydrophobic]2G[negatively charged]RF [61,111]. The biological rele-
vance of Gcn1 function in the activation of Gcn2 in vivo has already
been discovered in other organisms.
In mammals, Gcn1 contains an amino acid equivalent to Arg-2259,
with the surrounding sequences being evolutionary conserved [111].
In mammalian cells, Gcn1 complexes with Gcn2 as shown by co-
immunoprecipitation experiments [92], and both proteins interact
with translating ribosomes [112]. Furthermore, in mammalian cells,
overexpression of a mammalian Gcn1 fragment equivalent to yeast
Gcn12052–2428 impairs Gcn2 function under amino acid deprivation
or proteasome inhibition (Section 4) [92]. Similarly, overexpression
of IMPACT, a protein proposed to disrupt Gcn1–Gcn2 interaction
(Section 9), impairs Gcn2 activation under amino acid deprivation, UV
stress, glucose starvation, and proteasome inhibition [92].
Fig. 4. Schematic representation of yeast Gcn1. The Gcn1 middle portion has homology to the eEF3 N-terminus (hatched) [101]. Areas indicated with double arrows are required for
ribosome association [61], sufﬁcient for Gcn20 binding [99], and required and sufﬁcient for Gcn2 binding [61]. Amino acids are shown for which a biological function was discovered.
12 basic residues (dubbed area M7) and the sequence motif ExxWRTKR (dubbed area M1) are required for efﬁcient ribosome binding [108]. Gly-1444 is required for Gcn20 binding
[99]. Arg-2259 is speciﬁcally required for Gcn2 binding in vitro and in vivo [61]. Phe-2291 is required for Gcn2 binding in vivo [107]. For more see text.
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manner [26]. Gcn1 is also involved in C. elegans morphogenesis. Loss-
of-functionmutations in Gcn1 or PERK, independently, suppress the de-
fect of semaphorin mutants. Semaphorin-mediated signaling governs
ray morphogenesis in the male tail, by reducing eIF2α phosphorylation
[113]. Interestingly, however, knock-down of Gcn2 in semaphorin mu-
tants leads to reduced eIF2α phosphorylation in the whole organism,
but not in the ray precursor cells and this correlates with unaffected
ray morphogenesis. It is possible that Gcn2 is not sufﬁciently knocked
down in the ray precursor cells, or that Gcn1 has a Gcn2-independent
role in this differentiation process.
Gcn1 is involved in embryogenesis in Arabidopsis, for which it was
initially named after the Greek goddess of childbirth, ILITHYIA [114],
and it is required for plant fertility and immunity against Pseudomonas
syringae infections [115]. AtGcn1 has homology with eEF3 as found for
scGcn1. Also, AtGcn1 contains an amino acid equivalent to ScArg-2259
(here Arg-2348), within the consensus sequence ITGPLIR[bulky
hydrophobic]2G[negatively charged]RF, which would support the idea
that Arabidopsis Gcn1 interacts with Gcn2 [111]. The involvement of
AtGcn2 in the above processes still remains to be veriﬁed.
Gcn1 may bindmore proteins than those known so far, since it con-
tains N20 HEAT repeats distributed throughout its length [103]. HEAT
repeats are proposed to serve as interaction sites for other proteins
and nucleic acids, suggesting that Gcn1 is a scaffold protein [103].
Despite its size and the presence of multiple HEAT repeats, large scale
interaction studies did not consistently reveal any Gcn1-interactors,
not even the known Gcn1-binding partners (Gcn2, Gcn20, Gir2, Yih1)
(e.g. [116–119]). Thus, it is possible that protein–protein interactions
with Gcn1 are too weak or transient to withstand the experimental
procedures employed in these large scale studies.
Gcn1 forms a complexwith Gcn20. Gcn20, or the Gcn1–Gcn20 inter-
action, promotes, but is not absolutely necessary for Gcn2 activation
in vivo [99,120]. The Gcn20 C-terminus has homology to the C-
terminus of eEF3 including the ATP binding cassettes (ABC) [120].
Both proteins belong to a subfamily of the ABC proteins that harbor
twin ABC cassettes, but unlike other subfamilies they lack transmem-
brane domains [121].
The N-terminus of Gcn20 (residues 1–189) binds to the eEF3-like re-
gion in Gcn1 (amino acids 1330–1617), and this interaction ismediated
by Gly-1444 in the eEF3-like region [99,120]. Gcn20 has an intrinsic
ribosome binding activity, albeit weak, as detected by polysome co-
sedimentation assays [99]. In the presence of ATP, the Gcn1–Gcn20
complex has a higher afﬁnity for ribosomes than either protein alone,
and this effect is predominantly mediated by the Gcn20 C-terminus,
suggesting that Gcn20 promotes Gcn1/20–ribosome interaction [99].Interestingly, in the absence of ATP, Gcn20 negatively regulates
Gcn1–ribosome interaction [99]. Seemingly at odds with the co-
sedimentation studies, the Gcn20 C-terminus is largely dispensable
for promoting Gcn2 activation in vivo [99]. Thus, ATP mediated
increased Gcn1–polysome interaction is dispensable for sensing
amino acid starvation. It was proposed that the Gcn20 C-terminus
modulates Gcn1–ribosome interaction under certain conditions in
order to ﬁne-tune Gcn2 activation.
A functional homologue of yeast Gcn20has not yet been identiﬁed in
humans, but considering the conservation of the Gcn2 regulatory mod-
ule it is very likely that it does exist. The mammalian ABC-containing
protein ABC50 described to participate in translation initiation, has
some similarity with Gcn20 (20% identity and 30% similarity between
their N-terminal region), but it cannot substitute for Gcn20 function in
yeast [122]. However, as one cannot exclude the possibility of evolu-
tionary divergence, it remains to be tested whether ABC50 interacts
with mammalian Gcn1 [122].
In Plasmodium falciparum a homologue of Gcn20 was identiﬁed
(PfGcn20), which complements a yeast gcn20Δ strain [123,124]. Inter-
estingly, in certain developmental stages PfGcn20 is secreted into the
infected erythrocyte [125]. It will be interesting to assess whether
PfGcn20 participates in the regulation of Gcn2 in these parasites [126].
6. Working model for Gcn2 signal sensing
The evidence gathered thus far from work in S. cerevisiae has result-
ed in aworkingmodel of howGcn2 detects tRNAdeacyl under amino acid
starvation, as depicted in Fig. 5A [61,98,99]. Gcn1 and Gcn2 form a tri-
meric complex with the ribosome. Considering that Gcn20 associates
with Gcn1, it is possible that Gcn20 is an integral part of this complex
(Section 6), however, for simplicity, and as Gcn20 is necessary but not
essential for Gcn2 activation, Gcn20 will not be further mentioned in
this section. For eukaryotic ribosomes it was shown that tRNAdeacyl
can enter the A-site in a codon-dependent manner in vitro [127].
When tRNAsdeacyl accumulate in the cell, the A-site of translating ribo-
somes may accommodate a cognate tRNAdeacyl, in particular when the
cognate charged tRNA is scarce (Fig. 5A, step 1). This tRNAdeacyl is then
transferred from the A-site to Gcn2 (Fig. 5A, step 2). The tRNAdeacyl
entering the A-site prior to its detection by Gcn2 ensures that Gcn2
detects this starvation signal rather than tRNAdeacyl naturally occurring
during the translational process. Gcn1 may function by delivering, or
facilitating the entry of, tRNAdeacyl into the A-site, or by transferring
tRNAdeacyl from the A-site to Gcn2. Alternatively, it is possible that
Gcn1 is a scaffold protein that positions Gcn2 on the ribosome in such
a way that tRNAsdeacyl can be transferred directly from the A-site to
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requires Gcn1 to deliver it to Gcn2, mutations were found in the
Gcn2 kinase domain (R794G; F842L) that render it constitutively
active in vivo, bypassing the requirement for ribosome as well as
for tRNAdeacyl binding, and simultaneously bypassing the require-
ment for Gcn1 [49].
The hypothesis that Gcn2 is activated by an A-site bound cognate
tRNAdeacyl is based largely on the bacterial RelA protein. RelA governs
the ‘stringent response’ in which amino acid-starvation leads to the
synthesis of guanosine tetra- and pentaphosphate ((p)ppGpp), an
alarmone that mediates the regulation of a large number of adaptive re-
sponses [128–130]. In bacteria, in vitro studies suggest that the increase
in tRNAsdeacyl as a result of amino acid starvation facilitates entry of
tRNAdeacyl in the ribosomal A-site. In vitro data support a model in
which cognate tRNAsdeacyl can enter the A-site of prokaryotic ribosomes
in aweak but codon-dependentmannerwithout the aid of other factors
[131,132]. RelA binds to 70S ribosomes, and upon recognition of A-site-
bound tRNAdeacyl, it converts ATP and (GTP)GDP into (p)ppGpp which
simultaneously provides the energy for RelA to dissociate off the ribo-
some [133]. The enzymatic activity of RelA does not affect the amount
of tRNAdeacyl bound to the A-site, suggesting that RelA does not remove
tRNAdeacyl from the ribosome. After the cell has overcome starvation, the
tRNAdeacyl may be chased out of the A-site by the cognate charged tRNA
in complex with EF-Tu-GTP [133]. It has been proposed that RelA ‘hops’
from ribosome to ribosome to detect the presence of tRNAsdeacyl at A-
sites, thereby the amount of synthesised (p)ppGpp reﬂects the amount
of ‘starved’ ribosomes [133]. Recently, in vivo single-molecule imaging
studies suggest that amino acid starvation causes the release of RelA
from ribosomes as predicted from the in vitro data, and that RelA
synthesises several (p)ppGpp molecules per ‘hopping’ event [134].
This raises the possibility that RelA remains active for some time after
release from the ribosome [134]. This RelA ‘hopping’ model would beFig. 5. (A)Workingmodel for Gcn2 activation by uncharged tRNAs (tRNAdeacyl). [61,98,99] Gcn
(1) Under amino acid starvation, or other stress conditions that lead to increased levels of tRNA
tRNA is then transferred to the HisRS-like domain in Gcn2, (3) leading to the stimulation of the
directly involved in the transfer of the starvation signal to Gcn2. Areas in Gcn1 and Gcn20 that h
Gcn2 bind, the ribosome is drawn in a simpliﬁed manner. (Figure adapted from [61]) (B) Work
with Gcn2 for Gcn1 binding, thereby preventing transfer of the starvation signal to Gcn2 and
suggest that Yih1 resides in the cell in an inactive heterodimeric complex with an actin monomakin to the proposed idea that Gcn1/Gcn2 is in a dynamic equilibrium
between free and ribosome-bound forms.
There is support for the idea that Gcn1 and Gcn2 form a trimeric
complex with the ribosome to facilitate transfer of tRNAdeacyl from the
A-site to Gcn2. First, the (major) binding domains in the Gcn1 and
Gcn2 proteins required for Gcn1–Gcn2 interaction are physically
distinct from the ribosome binding domains in either protein (Figs. 3,
4) [61,70,98]. Second, Gcn1 binding to the ribosome causes sensitivity
to the A-site-binding drug paromomycin, suggesting that Gcn1 can
access/affect the A-site directly or indirectly [61] (Section 6).
Curiously, Gcn1 and Gcn2 are far less abundant in the cell than ribo-
somes [135], as found for RelA (one RelA molecule per 200 ribosomes,
[136]). Yeast cells grown in rich medium contain 7330 Gcn1 and only
279 Gcn2 molecules [135]. Taken into consideration results from poly-
some co-sedimentation proﬁles (cells grown in minimal medium) to
gage the steady state distribution of the Gcn proteins [137], and assum-
ing that the cellular amount of Gcn proteins does not change signiﬁcant-
ly depending on the growth medium, it is possible to reach an
approximate estimate that 2430 Gcn1 and 74 Gcn2 molecules reside
on the polysomes, and 2300/124 Gcn1/Gcn2 molecules reside on 80S
and monosomes. As Gcn2 forms dimers (or even tetramers) [39–41],
only 37 (or less) translating ribosomes would carry Gcn2. With the far
higher abundance of ribosomes (200,000 in cells grown in richmedium
[138]), the likelihood of Gcn1 and Gcn2 simultaneously contacting the
same translating ribosome is extremely low. There are indications that
Gcn1 and Gcn2 form a complex that ‘hops’ on and off the ribosome,
thereby ensuring that both proteins reside on the same ribosome to
allow tRNAdeacyl detection by Gcn2. For example, Gcn1 co-precipitates
Gcn2 but not the integral 60S ribosomal protein Rpl39, and the
ribosome binding activity of Gcn2 and Gcn1 are dispensable for Gcn1–
Gcn2 interaction [38,61]. These data would also explain an observation
that cells with 50% reduction in Gcn1 protein levels are still able to1 and Gcn2 bind to the ribosome, and contact each other involving the Gcn2 RWD domain.
sdeacyl, a cognate tRNAdeacyl enters the ribosomal A-site in a codon speciﬁc manner. (2) This
kinase domain, auto-phosphorylation, and phosphorylation of its substrate eIF2α. Gcn1 is
ave homology to eEF3 are shaded. Because it is unknownwhere on the ribosome Gcn1 and
ing model for Gcn2 regulation by Yih1. [165] (4) The RWD domain of free Yih1 competes
impairing Gcn2 activation. (5) The Gcn2-inhibitory function of Yih1 is regulated. Studies
er. So far the cue leading to Yih1 dissociating from actin is unknown.
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(Shanmugam & Sattlegger, unpublished and [139]).
The Gcn1–Gcn2 complex may randomly probe ribosomes for the
presence of tRNAsdeacyl in the A-site. It is possible that the Gcn1–Gcn2
complex only recognises ribosomes which are in a certain stage in the
elongation cycle, such as those that have accommodated a tRNA in the
A-site but do not carry eEF3 [140] (see below). Under nutrient replete
conditions, basal Gcn2 activity may be maintained by a rare event of
tRNAsdeacyl occurring in the A-site, thereby ensuring basal Gcn4/ATF4
protein levels and basal expression levels of the Gcn4/ATF4 target
genes [140] (see Section 8). Studies suggest that eEF3 triggers the
release of tRNAdeacyl from the E-site during normal protein synthesis
[104]. In analogy to this, Gcn1 may trigger the release of tRNAdeacyl as
well, but from the A-site [101].
One approach to test the above model for Gcn2 signal sensing
would require the development an in vitro assay using highly puriﬁed
components. However, complicating the matter, studies hint towards
Gcn2 becoming (partially) activated during cell breakage, possibly due
to reduced tRNA charging in the cell extract, and/or due to the mixing
of cell content and the concomitant exposure of Gcn2 to tRNAdeacyl or
immature tRNAs that are normally not accessible to Gcn2 in vivo [57].
The model on starvation sensing by Gcn2 on the ribosomewas built
entirely on experimental evidence obtained in the yeast system.
Although all the available information attests that tRNAdeacyl is the
immediate signal for Gcn2 activation in all organisms investigated, the
details of this model are still far from being understood relative to the
participation of Gcn1 and the ribosomes in the activation of Gcn2, in
yeast and other organisms. Mouse Gcn2 overexpressed in a gcn2Δ
yeast strain is capable of phosphorylating eIF2α. It dampens cell growth
even in replete medium, in a manner dependent on eIF2α Ser-51,
possibly due eIF2α hyperphosphorylation. Curiously however, the
growth defect is dependent on the m2 amino acids in Gcn2, but not
on endogenous Gcn1. One possible reason for Gcn1 being dispensable
may be the fact that the mammalian Gcn2 was overexpressed thereby
artiﬁcially giving Gcn2 access to tRNAdeacyl [13].
Gcn2 variants have been described that lack the RWD domain
required for Gcn1 binding. For example, in mouse, besides the bonaﬁde
Gcn2 that has homology to the entire length of yeast Gcn2 (Gcn2β
isoform), two additional mRNAs were found encoding Gcn2 isoforms
that differ in their N-terminus [13]. The γ form lacks part of the RWD
domain (amino acids 1–86, equivalent to yeast Gcn2 residues 1–77)
and harbours 8 amino acids unique to this isoform; and the α form
lacks all RWD amino acids up to the pseudokinase domain (residues
1–197, equivalent to yeast Gcn2 residues 1–188). Although the RWD
domain is truncated in the γ isoform, results from studies on the Yih1
RWD domain suggest that this truncated Gcn2 RWD domain may
still be able to bind Gcn1 (see below) [64]. Thus only the α isoform
completely lacks the Gcn1 interacting region. The Gcn2β mRNA is
expressed in all examined organs (heart, brain, liver, lung, skeletal
muscle, kidney, testis [12,13], and ovaries and oocytes [30]). The
mRNAs of the other 2 isoforms are restricted to speciﬁc tissues
(Gcn2γ in brain and testis; Gcn2α in brain, liver and testis [13]; no
Gcn2αwas detected in oocytes [30]). Given the expected size difference
between the Gcn2α and the Gcn2β isoforms, Gcn2α should be detected
in immunoblots of the mouse brain. However, no clear signal has been
obtained with the expected size [141]. It is possible that Gcn2α is
expressed in speciﬁc cells, which would not be sufﬁcient for detection
in extracts of whole brains or brain parts. Thus, an important issue
that needs to be determined is whether the Gcn2α and Gcn2γ isoforms
are expressed and functional, and to what conditions they respond to
phosphorylate eIF2α.
RWD-less Gcn2 forms have also been found in other organisms. One
of the two Gcn2-like kinases identiﬁed in the parasite T. gondii lacks the
Gcn1-interacting RWDdomain (TgIF2K-C). It is activated in intracellular
parasites when glutamine is withdrawn from the host cell growth
medium, and is required for parasite adaptation to imposed glutaminestarvation on the host [142]. A close homolog in the malaria parasite
P. falciparum (PfeIK1) also lacks the RWD domain [142] and is regulated
by amino acid starvation [126]. In Dictyostelium, two of the three Gcn2-
like kinases also lack the RWD domain [142–144]. It is possible that the
Gcn2 isoforms lacking the RWD domain are activated by a mechanism
that does not require Gcn1. In another scenario, the RWD-less Gcn2
may heterodimerise with and thereby regulate full-length Gcn2
in vivo. This important issue must be addressed in the future to further
our understanding on the regulatory mechanisms impacting on Gcn2
activity in these other organisms or in mammalian cells that may
express those alternative Gcn2 isoforms.
7. Translation elongation factors
Studies in S. cerevisiae suggest that the essential translation elonga-
tion factors eEF1A and eEF3 keep Gcn2 in its latent state under nutrient
replete conditions [140,145]. eEF3 mediates the release of tRNAdeacyl
from the E-site during each round of translation elongation, and this is
coupled with eEF1A-mediated delivery of a cognate amino-acyl tRNA
to the A-site [104,105,146]. eEF3 has two ATP binding cassettes and its
ATPase activity is enhanced by ribosomes in vitro [146,147]. A homo-
logue to eEF3 was not found in higher eukaryotes so far. In contrast to
yeast ribosomes, mammalian ribosomes seem to have an intrinsic
ATPase activity, and in vitro studies suggest that this may constitute
the eEF3-equivalent function in these organisms [148,149]. Prokaryotes
harbor a soluble ATPase, RbbA, that associates with ribosomes and may
be the equivalent to eEF3 [150–152].
In vitro co-precipitation studies showed that eEF1A directly binds to
the Gcn2 CTD, and in vitro kinase assays revealed that eEF1A inhibits
Gcn2-mediated eIF2α phosphorylation but not Gcn2 autophosphoryl-
ation [153]. eEF1A may prevent Gcn2 from binding its substrate eIF2α
[153]. Alternatively, considering that Gcn2 activation requires relief of
autoinhibitory interactions and a rearrangement of the Gcn2 conforma-
tion, this raises the possibility that eEF1A may prevent the complete
intramolecular rearrangement of Gcn2. This would allow ATP binding,
but would not allow eIF2 to access the active site [153].
Gcn2–eEF1A interaction is reduced under starvation conditions
in vivo, and this may be explained by the observation that tRNAsdeacyl
dissociate eEF1A–Gcn2 interaction in vitro. As the Gcn2-CTD constitutes
part of the tRNAsdeacyl binding site [69], one could envision that under
amino acid starvation tRNAsdeacyl are channelled to Gcn2, dissociating
eEF1A from Gcn2, thereby allowing Gcn2 activation [153].
eEF1A is also known to be implicated in a large array of other non-
canonical functions that are seemingly unrelated to its function in
protein synthesis [154,155]. For example, eEF1A regulates the actin
cytoskeleton in eukaryotes by binding and bundling ﬁlamentous actin
(F-actin) [155–157]. Conversely, actin regulates eEF1A [154,155]. For
example, while bound to F-actin, eEF1A is unable to bind aminoacyl-
tRNAs, suggesting that actin-binding drives eEF1A into its translation-
inactive form. This raises the possibility that actin utilises eEF1A to
also modulate Gcn2 activity.
Mammals harbor two eEF1A isoforms that function in protein
synthesis but differ in their expression patterns. eEF1A2 is present
during fetal development, and later-on is replaced by eEF1A1 in almost
all tissues [158]. Increased abundance of eEF1A2 has been found in
several tumours [158], and ectopic expression of this protein is tumori-
genic [159]. It was reported that eEF1A1 can also be transforming as
found for eEF1A2 [159]. Since Gcn2 activity has been shown to promote
tumour growth [22], it will be relevant to address whether in cancer
cells Gcn2 activity is modulated by some of the non-canonical functions
of overexpressed eEF1A. For example, it is unknown whether free or
actin-bound eEF1A inhibits Gcn2, or whether eEF1A1 and eEF1A2 differ
in their afﬁnity to Gcn2 or actin. Interestingly, eEF1A from metastatic
cells has reduced F-actin afﬁnity in vitro [160].
Overexpression of eEF3 leads to reduced eIF2α phosphorylation
even under replete conditions [140]. Genetic studies suggest that this
Fig. 6. Model for translation elongation factors keeping Gcn2 in its latent state. During
protein synthesis eEF3 binding to the ribosome prevents the formation of a functional
Gcn1–ribosome complex (see Fig. 5 for comparison), thereby preventing delivery of
tRNAsdeacyl to Gcn2 [140]. In addition, eEF1A bound to the Gcn2 CTD prevents Gcn2
from phosphorylating eIF2α [153]. It remains to be determined whether the eEF1A
inhibitingGcn2 is different to the one delivering aminoacyl-tRNA to the A-site, orwhether
this eEF1A is its GTP- or GDP-bound form. Areas in Gcn1 and Gcn20 with homology to
eEF3 are hatched.
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a functional Gcn1–ribosome interaction. Supporting this idea, Gcn2 ac-
tivation is further impaired when eEF3 overexpression is combined
with the Gcn1 M7Amutation known to have reduced ribosome afﬁnity
(amino acids in Gcn1 area M7 are substituted by alanine (chapter 5))
[140]. Furthermore, Gcn2 activation can be impaired by overexpressing
eEF3 fragments that harbor only the ribosome binding activity, such as
the eEF3 C-terminus (910–1044), or the eEF3 N-terminal HEAT domain
(amino acids 100–367) which has homology to Gcn1 [140]. Together,
these observations indicate that Gcn1 and eEF3 have common binding
sites on the ribosome [140]. However, polysome co-sedimentation
studies indicate that eEF3 overexpression does not reduce Gcn1–
ribosome interaction, suggesting that eEF3 does not remove Gcn1
from the ribosome. It is possible though that the effect of eEF3 over-
expression on the steady-state level of Gcn1–ribosome association
may be too small for being detected by the employed assay. Since
Gcn1 has a large ribosome binding region, eEF3 overexpression is likely
to only affect a few of the Gcn1 ribosome contact points, in particular
the ones that are crucial for Gcn1 function.
As a result of these observations, these elongation factors can be
added to the current workingmodel for Gcn2 activation (Fig. 6). During
each round of translation elongation, eEF3 transiently binds to the ribo-
some to facilitate release of tRNAdeacyl from the E-site. eEF3–ribosome
binding would impair the formation of a functional Gcn1–ribosome
complex. In addition, eEF1A bound to the Gcn2 CTD would prevent
Gcn2 from phosphorylating its substrate eIF2α. Under conditions
where the cognate charged tRNA is scarce, tRNAdeacyl enters the A-site
in a codon-dependent manner. Accommodation of A-site bound
tRNAdeacyl would not lead to the release of E-site bound tRNAdeacyl,
thus eEF3 function would be redundant. The absence of eEF3 from the
ribosome would allow Gcn1 to form a productive Gcn1–ribosome com-
plex and to promote delivery of tRNAdeacyl from the A-site to Gcn2. This
tRNAdeacyl would trigger eEF1A to dissociate from Gcn2 CTD, allowing
full Gcn2 activation and eIF2α phosphorylation [140,145]. While the
mechanism leading to eEF1A–Gcn2 dissociation under starvation condi-
tions remains to be determined, current data suggest that tRNAsdeacyl
are a contributing factor [140]. The fact that eEF3 overexpression also
reduces basal eIF2α phosphorylation levels suggests that a low amount
of tRNAsdeacyl occurs in theA-site even under replete conditions, leading
to basal Gcn2 activity and basal eIF2α phosphorylation levels and thus
basal levels of amino acid biosynthesis [140].
8. Yih1/IMPACT
In a search for imprinted genes in mice, a protein was uncovered
that consisted of two domains [161]. Its C-terminal domain has
sequence homology with proteins found in all kingdoms of life, for
which the domain was called the ancient domain, and the mouse gene
was named Impact for imprinted gene with ancient domain [161,162]
(Fig. 7A). The N-terminal domain in IMPACT shares sequence similarity
with theGcn2N-terminus, and also constitutes anRWDdomain [62,64].
The gene encoding IMPACT is present in most eukaryotes [64,137,161,
163,164].
The IMPACT protein in S. cerevisiaewas called Yih1, for yeast Impact
homologue [62]. Based on the discovery that the RWD domain of Gcn2
contacts its effector protein Gcn1 [61,62], it was proposed that IMPACT/
Yih1 inhibits Gcn2 function by competing with Gcn2 for the interaction
with Gcn1, mediated by its RWD region [62]. Supporting this idea, over-
expression of the Yih1 RWDdomain (amino acids 1–125)was shown to
be sufﬁcient for impairing cell growth under amino acid starvation
conditions [62]. Evidence that Yih1 is a de facto negative regulator of
Gcn2 by competing for Gcn1 binding was subsequently provided [64,
165], by showing that: a) impaired growth under amino acid starvation
observed with cells overexpressing Yih1 is reverted by increased Gcn2
levels; b) Yih1 overexpression reverts the growth defect associated
with constitutively active Gcn2; c) in vivo overexpressed Yih1 co-precipitates Gcn1 but not Gcn2, reduces the cellular level of Gcn1–
Gcn2 interaction, and leads to reduced phosphorylation of eIF2α; and
d) puriﬁed Gcn12052–2428 binds to puriﬁed Yih1 in vitro and this inter-
action is dependent on the Gcn1 Arg-2259 residue, similarly to the
Gcn1–Gcn2 interaction.
Several lines of evidence indicate that the function of IMPACT/Yih1
is evolutionarily conserved: a) puriﬁed yeast Gcn12052–2428 co-
precipitates IMPACT from mouse brain extracts, in an Arg-2259 depen-
dent manner [111]; b) endogenous IMPACT co-immunoprecipitates
with Gcn1 in mouse brain extracts [111]; c) in mouse embryonic ﬁbro-
blasts (MEFs), overexpressed IMPACT leads to reduced Gcn1–Gcn2 in-
teraction [92]; d) IMPACT overexpressed in yeast inhibits Gcn2 in a
variety of stress conditions that depend on Gcn1, as found for
overexpressed Yih1 [92,111]; e) IMPACT overexpression in MEFs in-
hibits endogenous Gcn2 activation under amino acid or glucose starva-
tion conditions, UV irradiation and proteasome inhibition, as
determined by its auto-phosphorylation levels and the downstream re-
sponse of eIF2α phosphorylation [92,111]; f) knock-down of endoge-
nous IMPACT in undifferentiated neuronal-like N2a cells, which
express high levels of IMPACT, resulted in stronger Gcn2 activation
under leucine starvation conditions; [112]; g) in differentiated neuronal
N2a cells, where IMPACT is even more abundant, knock-down experi-
ments showed that endogenous IMPACT inhibits basal Gcn2 activi-
ty [112]; h) IMPACT does not inhibit PERK activation, as expected
given that of the four mammalian eIF2α kinases, only Gcn2 contains
an RWD domain [3,92].
Similarly to IMPACT-knock down in undifferentiated neuronal cells,
deletion of Yih1 in yeast does not lead to a detectable increase in basal
eIF2α phosphorylation [165]. To rule out the possibility that the Gcn2-
inhibitory function of Yih1 is redundant with other proteins, all genes
known to code for a protein with an N-terminal RWD-domain were
deleted in the same yeast cell. Even then these cells did not show
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Yih1/IMPACT may be required under speciﬁc conditions, or in speciﬁc
cells or cellular locations, where Gcn2-activity must be efﬁciently
inhibited to allow for maximum rate of protein synthesis. This will be
discussed later.
In vivo co-sedimentation and co-precipitation assays showed that
endogenous, as well as overexpressed, Yih1 binds to translating ribo-
somes in a Gcn1-independent manner, and the same was found for
IMPACT expressed in yeast [137]. Yih1 overexpression does not affect
Gcn1–polyribosome or Gcn2–polyribosome interaction, indicating that
Gcn1, Gcn2 and Yih1/IMPACT bind to the ribosome independently of
each other [137]. The same may be true for the mammalian system
since neuronal endogenous IMPACT also associates with polyribosomes
[112]. It should be noticed that, both in yeast and in mammals, only a
fraction of endogenous Yih1/IMPACT associates with polyribosomes
[112,137]. Yih1/IMPACT may transiently associate with ribosomes or
have additional functions unrelated to Gcn2 regulation.
Yih1/IMPACT–Gcn1 interaction must be somehow regulated, as
otherwise Yih1/IMPACT would constitutively inhibit Gcn2 [165].
Supporting this idea studies in yeast uncovered that Yih1 function is
regulated by actin. Yih1, expressed from its chromosomal locus and
tagged with a ﬂag epitope, forms a complex with monomeric actin (G-
actin) in a 1:1 molar ratio, as determined by subjecting the Flag-
immunoprecipitated material to separation on size exclusion chroma-
tography or on velocity sedimentation on glycerol gradient [165].
IMPACT co-precipitates yeast actin in vivo, supporting the idea that
IMPACT/Yih1–actin interaction is evolutionary conserved [137]. In vivo
assays using gcn1Δ strains showed that the Yih1–actin interaction
does not require Gcn1, while in vitro binding assays indicated that
Yih1–Gcn1 interaction does not require actin [64,165]. These data
support the idea that Yih1 may shuttle between its binding partners
actin and Gcn1 (see below).
Indication that the connection of Yih1 and actin is relevant in vivo
was obtained. Genetic reduction in actin levels, in heterozygous ACT1/
act1 diploid yeast strains, impairs the cell's ability to overcome amino
acid starvation, and this in turn can be partially reverted by deleting
YIH1 [165]. The fact that in wild-type yeast cells endogenous Yih1 co-
puriﬁedwith actin but not with Gcn1 led to amodel where Yih1 resides
in the cell in an inactive Yih1–G-actin complex, andwhen released from
actin, under certain conditions or in certain cellular locations, it then in-
hibits Gcn2 (Fig. 5B) [165]. Experimental support for this model would
require showing that reduced actin levels increase Yih1–Gcn1 inter-
action at the expense of Gcn1–Gcn2 interaction, and that this is
associated with reduced phosphorylation of eIF2α. However, this
could not be observed so far, possibly because of the technicalities of
the experimental procedure. Alternatively, Yih1 could be conﬁned to
inhibiting Gcn2 in certain regions of the cell where maximal protein
synthesis is required. There are precedents for localised regulation ofFig. 7. (A) Overview of the Yih1 protein. In the RWD domain the location of motif YPxxx(x)P (a
acids in RWDdomain helix 2 (h2) are shown that when substituted by Ala increase interaction
Gcn1bindingbut not actin binding. The ancient domain harbours loop regions that forma conse
that harbours determinants characteristic to either eukaryotes or prokaryotes (purple). The li
proteins from higher eukaryotes (+/−) (B) Double arrows depict regions in Yih1 that are sufﬁc
impact on the respective binding properties are indicated by grey boxes.translation especially in neurons, but none has been described yet
involving eIF2α phosphorylation [154,166,167]. The actin cytoskeleton
provides a scaffold for components of the translational machinery
[154], and its high rate of re-organisation in speciﬁc cell locations
would allow for actin to mediate Yih1/IMPACT regulation of localised
Gcn2 activity [64,137,165].
Interestingly, in neuronal N2a cells, IMPACT promotes neurite
outgrowth induced by serum starvation. Conversely, Gcn2 inhibits
spontaneous neurite outgrowth [112]. The involvement of IMPACT in
induced N2a cell differentiation was, at least in part, mediated by its
inhibition of Gcn2. Therefore, the possibility that IMPACT also functions
in Gcn2-independent pathways is open to further studies. In primary
hippocampal neuronal cultures, Gcn2 also negatively controls neuronal
process extension [112]. Neurite outgrowth involves extensive actin
remodelling, but it remains to be established whether actin modulates
the ability of IMPACT to inhibit Gcn2. In addition, during the differenti-
ation process, Gcn2 activity showed a marked decrease, as determined
by its auto-phosphorylation levels in immunoblots, concomitant with
the increase in the abundance of IMPACT. However, no detectable
decrease in eIF2α phosphorylation was observed. This was probably
due to the observed concurrent activation of PERK [112]. These observa-
tions may raise the possibility of a localised control of eIF2α phosphor-
ylation by Gcn2, an event that cannot be detected by immunoblots of
cell extracts, much in the same manner as Yih1 in the yeast model
proposed above. These observations strengthen the necessity for further
investigations, to address whether translation can be locally regulated
by eIF2α phosphorylation mediated by Gcn2, and whether IMPACT
regulates Gcn2 in subcellular locations.
In Xenopus oocytes, overexpression of IMPACT by microinjection
leads to increased rates in gastrulation defects, indicating that its correct
dosage is critical during this developmental process [163]. It remains to
be veriﬁed whether this defect is due to Gcn2 inhibition.
More knowledge on the IMPACT/Yih1 domains may give a clue on
how different interacting partners determine the function of this
protein. Despite the low sequence conservation between the RWD
domains of Yih1 and Gcn2, the RWD-motif of Yih1 (amino acids
1–114) was successfully modelled on the Gcn2 RWD structure [64].
Intramolecular contacts found for Gcn2 RWD seem to be preserved in
Yih1, including the conserved YPxxx(x)P structural motif (Fig. 7A) [63,
64].
The ancient domain is found throughout all kingdoms of life,
suggesting that it is involved in a highly conserved and fundamental
biological process [64,161,162]. Its function however, remains elusive.
The E. coli YigZ protein is the prototype of an ancient domain, and its
structure has been solved by crystallography [168]. Modelling of the
Yih1 ancient domain (amino acids 125–258) suggests that it conforms
well to the structure of YigZ [64]. Interestingly, three invariant sequence
features found in both eukaryotes and prokaryotes (Fig. 7A) are presentmino acids 53–59) required for maintaining domain structure is indicated in black. Amino
with Gcn1 and actin, while substitution of the indicated amino acids in helix3 (h3) impairs
rved putative interaction surface for a yet-to-be discovered ligand (yellow andpurple), and
nker region contains an abundance of charged amino acids, which is more evident in the
ient for binding the indicated proteins or ribosome. Regions in Yih1 identiﬁed to negatively
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thesemotifsmay be involved in binding amolecule that is evolutionari-
ly conserved [64]. In addition, adjacent to these loop regions, and in a
forth loop, sequences are found that are unique to either the prokaryotic
or eukaryotic lineage [64].
The RWD and the ancient domains appear to be structurally largely
independent of each other, and are connected by a linker region with
low sequence conservation and longer in the vertebrate lineage [64].
This linker is rich in charged residues, similarly to what is found next
to the RWDdomain in Gcn2 [38]. The linker region seems to be unstruc-
tured, as indicated by biochemical studies, and prediction algorithms
such as FoldIndex [64,169]. Areas of structural disorder and low
sequence conservation are commonly associated with docking sites
for different interactors in regulatory proteins [170]. Indeed, we found
that the binding regions for Yih1-interacting proteins always encom-
pass part of or the entire linker region, as shown in Fig. 7B, and discussed
below.
In an effort to map binding regions in Yih1, in vivo co-precipitation
studies were conducted using a set of GST-tagged Yih1 fragments. It
was found that the interaction with Gcn1 is stronger with a Yih1 frag-
ment comprising amino acids 68–171, encompassing the C-terminal
part of the RWD domain and part of the highly charged linker region
[64] (Fig. 7B). In Gcn2, partial deletion of the highly charged region
adjacent to RWD (amino acids 184–237, Fig. 3) reduces Gcn1–Gcn2
interaction in vivo, suggesting that this region may also promote
Gcn1–Gcn2 interaction [38]. Co-sedimentation assays revealed that
the same Yih168–171 fragment harbours the main ribosome binding
determinant(s) [64]. The actin binding site was mapped to a region
encompassing part of the linker region and the ancient domain, amino
acids 68–259 (Fig. 5B) [64].
Yih1 fragment 68–171 encompasses RWD helices h2 and h3 [64].
Within h3, Asp-102 and Glu-106, which are conserved in the Gcn2
RWD h3 helix (Glu-125, and Glu-136), are required for Gcn1 binding,
but not for actin binding. As expected, Ala substitutions of these two
residues impair the ability of overexpressed Yih1 to inhibit Gcn2. It
will be interesting to verify whether the respective amino acids in
Gcn2 RWD h3 also contact Gcn1 as suggested by [63]. Interestingly,
Ala substitutions of Glu-87 and Asp-90 in h2 increase the ability of
Yih1 to inhibit Gcn2, and this correlates with its stronger afﬁnity to
Gcn1, but also to actin. Together, these data strongly suggest different
but overlapping determinants for actin and Gcn1 binding.
Binding properties seem to be subject to intra-molecular regulation
(Fig. 7B).Whenever Yih1 fragments lack any of the termini (amino acids
1–67 or 172–258), Yih1–Gcn1 interaction is enhanced relative to that of
full-length Yih1, suggesting that both termini negatively regulate Yih1–
Gcn1 interaction. For actin and the polyribosome interaction, only the
Yih1 N-terminus appears to have negative effects. Together this
suggests, Yih1 function and regulation may be more complicated than
anticipated [64]. It remains to be determined whether Yih1 exclusively
binds actin, ribosomes and Gcn1, and whether one binding protein
regulates the interaction of Yih1with one ormore of the other proteins.
These studies provided insights into how Yih1, and perhaps IMPACT
as well, function in inhibiting Gcn2. The overlap in Gcn1- and actin-
binding sites suggests that Yih1 binds either one or the other protein
[64]. Curiously, the efﬁciency of a Yih1 fragment in interacting with
Gcn1 does not necessarily dictate its ability to inhibit Gcn2 activation.
In particular, Yih168–258 sequesters more Gcn1 than full length Yih1
but yet is less effective in impairing Gcn2 function [64]. This Yih1 frag-
ment lacks helix h1, and the XPxxx(x)P motif, necessary to stabilise
the conformation of h2 and h3 in the RWD, raising the possibility that
this truncated RWD domain is unable to displace Gcn1 from pre-
formed Gcn1–Gcn2 complexes. Thus, Yih168–258 may selectively bind
Gcn1 molecules that are not associated with Gcn2 and not involved in
Gcn2 regulation [64]. Supporting these ideas, not all Gcn1 appears to
be engaged in contacting Gcn2, because a) there are 26 times more
Gcn1 molecules than Gcn2 in the cell [135]; b) various polyribosomeco-sedimentation assays indicate that only about 60% of Gcn1 resides
on the ribosome [61,99,108,137]; and c) comprehensive protein–pro-
tein interaction studies found Gcn1 in several complexes lacking Gcn2
(e.g. [116–119]). In line with the idea that residues 1–67 are required
for efﬁciently disrupting Gcn1–Gcn2 interaction, full-length Yih1 with
the h2 amino acid substitutions also has increased afﬁnity to Gcn1 and
actin, except that it efﬁciently inhibits Gcn2 in contrast to Yih168–258
[64]. Considering that these h2 amino acids are predicted to be solvent
exposed, their charge may restrict access to Gcn1, and the Ala substitu-
tionswould thus facilitate better access of Gcn1 to its binding site on h3,
and better access of actin to its binding site. Possibly the increased actin
afﬁnity is counterbalanced by the increased Gcn1 afﬁnity to still allow
h2 mutated Yih1 to efﬁciently disrupt Gcn1–Gcn2 interaction. The
above ﬁndings raise the possibility that Gcn1 and Yih1/IMPACT play
additional roles in the cell apart from Gcn2 regulation. How Yih1/
IMPACT is directed to the Gcn1/Gcn2 complex remains to be deter-
mined. One possible mechanism is the recruitment of Yih1/IMPACT to
the ribosome where Gcn1 and Gcn2 are located as well [137].
While numerous large scale studies have shown that Yih1 expres-
sion does not change signiﬁcantly (see http://spell.yeastgenome.org),
IMPACT expression is highly regulated and may be relevant for ad-
justing Gcn2 function in speciﬁc tissues. The protein IMPACT is differen-
tially expressed in speciﬁc organs and cells in adult rodents, being
especially abundant in neurons in the central nervous system [111,
141]. The hypothalamus is exceptionally rich in neurons with high
IMPACT levels, particularly in the suprachiasmatic nucleus. Interesting-
ly, the basal level of eIF2α phosphorylation in the hypothalamus is the
lowest among the organs and brain parts analysed, suggesting that
IMPACT keeps basal Gcn2-activity at very low levels [111]. The hypo-
thalamus is in charge of maintaining body homeostasis such as con-
trolling temperature and the balance of ﬂuids and energy, and it is
constantly adjusting the organism's metabolism and behaviour to
its physiological needs. Along with this, protein synthesis must be
maintained at constant levels, suggesting that high IMPACT abundance
ensures low Gcn2 activity even under conditions in which Gcn2 would
be activated in other brain regions [141].
Gcn2 function has been associated with synaptic plasticity and hip-
pocampal memory [21,171]. Gcn2−/− mice have a lowered threshold
for the induction of the late phase of long term potentiation (L-LTP).
These mice show enhanced long term memory (LTM) in weak training
programs that in the wild type mice do not result in LTM. On the other
hand, Gcn2−/− are deﬁcient in L-LTP and LTM induced by normal
stimulation or strong training, respectively. Whether IMPACT partici-
pates in the modulation of Gcn2 activation in these paradigms remains
to be determined [33]. Given that IMPACT expression can be regulated
in neuronal cultures [112] (see above), it is possible that neuronal
stimulation may as well regulate the levels of IMPACT, thus providing
a means for the modulation of Gcn2 activity in L-LTP or LTM. In
mouse, several lines of evidence suggest that Gcn2 function in the
pyramidal neurons of the anterior piriform cortex is essential for
developing aversive behaviour against food lacking essential amino
acids [17,18,172]. It remains to be determined whether the same
neurons that show increased eIF2α phosphorylation upon intake of
this imbalanced food are devoid of IMPACT [141].
Together, these data indicate that IMPACT equips selected neu-
rons with specialised functions such as down-regulating the Gcn2-
dependent expression of ATF4, a protein proposed to play pivotal
roles in neuronal functions [171,173]. Alternatively, or in addition
to that, the highly abundant IMPACT in select neurons may function
in other aspects of neuronal biology that may be independent of
Gcn2, and this ﬁnds analogy with the data obtained for Yih1 in
yeast [64] (see above).
IMPACT also provides the means for other cell types to control
Gcn2. For example, human skin primary cells (ﬁbroblasts and
kerotinocytes) are more resistant than other cells (e.g. human T
cells, and an immortalised human T cell line (Jurkat cells)) to co-
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phan depletion from the medium, leading to Gcn2 activation. Inter-
estingly, human skin primary cells express high levels of IMPACT,
and knock-down of IMPACT in the primary human skin ﬁbroblasts
increases their sensitivity to co-cultured IDO-expressing cells [175].
Conversely, overexpression of IMPACT in Jurkat cells, which have
very little endogenous IMPACT, results in increased resistance
under conditions of Trp depletion [175].9. Gir2
Yeast Gir2 (Genetically Interacts with Ribosomal genes 2) is another
protein with an N-terminal RWD domain that interacts with Gcn1 as
determined by yeast-2-hybrid and pulldown assays. This interaction
also requires Gcn1 Arg-2259, as found for Yih1/IMPACT and Gcn2 [61,
111,165,176,177]. Overexpression of Gir2 inhibits Gcn2 function as
judged by impaired growth under starvation conditions, and reduced
eIF2α phosphorylation. This can be overcome by co-overexpressing
Gcn2, suggesting that Gir2 downregulates Gcn2 by competing with
Gcn2 for Gcn1 binding [176]. Deletion of Gir2 does not lead to increased
Gcn2 activity, suggesting that Gir2 is not a general/continuous Gcn2-
inhibitor as found for Yih1/IMPACT [165].
Unlike the RWD domains of other proteins studied so far, the Gir2
RWD is rich in acidic amino acids, particularly in an insert region unique
to Gir2 (residues 85–101), which together with a large part of the C-
terminus seems to be intrinsically unstructured [178,179]. It is possible
that, in contrast to the other RWD domains, the Gir2 RWD region only
folds into a structure homologous to the Gcn2 or Yih1/IMPACT RWD
when complexed with a partner such as Gcn1. The insert in the Gir2
RWD domain also contains a PEST sequence (amino acids 62–102),
known to target proteins for rapid degradation [179,180]. Supporting
the idea of Gir2 being prone to degradation, puriﬁed Gir2 is highly
sensitive to proteolysis [178].
The Gir2 C-terminus interacts with the small GTP-binding proteins
Rbg1 and Rbg2 (RiBosome interacting Gtpase), but seems to mainly as-
sociate with Rbg2 [176,177]. While most of Rbg1 is ribosome-bound,
only a small portion of Gir2 and Rbg2 is associatedwith translating ribo-
somes [176]. In contrast to Yih1/IMPACT, Gir2–ribosome association is
partially dependent on Gcn1 [176]. Interestingly, Gir2–Rbg2 complex
formation is enhanced by GTP, to some extent by GDP, but not by ATP
[177]. Mutational studies showed that this is dependent on the GTP-
binding domain in Rbg2, suggesting that Gir2–Rbg2 complex formation
reﬂects the cellular level of GTP, which in turn indirectly reﬂects the
cellular metabolic state. Guanine nucleotide enhanced interaction is
not affected by Gcn1, indicating that this complex formation occurs
independently of Gcn1 [177].
A biological relevance for the Gir2–Rbg interaction has been
proposed recently. Gir2 was found to be required for maintaining cell
doubling time, but only under amino acid starvation conditions, and
mutational analyses indicated that this is mediated by the Gir2/Rbg2
or Gir2/Rbg1 complex [177]. Interestingly, Gir2–Rbg2 complex levels
increase under amino acid starvation. These, as well as maintaining
the doubling time under amino acid starvation, are dependent on the
Rbg2 GTP binding activity [177]. Furthermore, amino acid starvation
leads to increased binding of Rbg2–Gir2 to Gcn1 [177]. It was suggested
that under amino acid starvation, Gir2–Rbg2 may sequester Gcn1 to
blunt further Gcn2 activation [177]. It is tempting to speculate that the
Rbg2–Gir2 complex adjusts the threshold level for Gcn2 activation to
the energetic state of the cell. As all translation elongation factors
(except of eEF3) consume GTP as an energy source, high GTP levels
would signal availability of sufﬁcient energy for proteins synthesis.
High GTP levels would allow the Gir2–Rbg2 complex to dampen the
Gcn2 response, thereby still allowing some general protein synthesis
to occur while the cell engages mechanisms to overcome amino acid
starvation [177].Mammals contain a Gir2 orthologue called RWD domain-containing
protein 1 (RWDD1, [181]) or developmentally regulated GTP-binding
protein family regulatory protein 2 (DFRP2, [182]). As in yeast its
main binding partner is the orthologue of Rbg2 called developmentally
regulated GTP-binding protein 2 (DRG2) [182,183]. Evolutionary
conservation of the Gir2–Rbg2 complex suggests its implication in a
central biological process(es).10. Viral proteins and RNA
Binding of viral RNAs to Gcn2 provides a mechanism for early cellu-
lar defence against a selection of viruses. In vitro, the Sindbis virus (SV)
genomic RNA binds and activates Gcn2 in a manner that is dependent
on the secondary structure of a bipartite sequence in the 5′ terminus
of the SV genome [96]. This Gcn2 activation requires the m2 motif in
the HisRS-like domain, suggesting that the viral RNA stimulates Gcn2
in the same manner as tRNAdeacyl [96]. SV infection in MEFs leads to
Gcn2 activation. This correlates with delayed synthesis of SV proteins
and impaired viral replication, events not detected in Gcn2−/− MEFs.
Furthermore, Gcn2 overexpression reduces SV replication and SV early
protein synthesis [96]. In mammalian cells, Gcn2 overexpression also
hampers the replication of other RNA viruses, such as the vesicular
stomatitis virus (VSV) and Semliki forest virus (SFV). Compared to
wild-type mice, Gcn2−/−mice are more susceptible to SV infection by
intranasal administration, showing increased virus titers in the brain
in the early days of infection [96].
In vitro transcribedHIV-1 genomic RNAalso activatesGcn2 in aman-
ner that is dependent on the m2 amino acids in the HisRS-like domain.
Furthermore, reporter gene studies suggest that Gcn2 silencing leads to
increased synthesis of HIV-1 proteins [184]. Gcn2 silencing in HeLa P4
cells relieves translational inhibition caused byHIV infection and results
in increased viral infectivity [185]. HIV-1 in turn has developed
counteractingmechanisms to inhibit Gcn2. At later times after infection,
cells infected with HIV-1 show signiﬁcant proteolytic degradation of
Gcn2 which can be prevented by saquinavir, an inhibitor of the HIV-1
protease HIV-1pro. In vitro assays conﬁrm that the Gcn2 cleavage is
catalysed by HIV-1pro, cleaving Gcn2 C-terminal to the Tyr within the
amino acid sequence Y[VI]ETVIP, thereby removing the N-terminal
RWD and pseudokinase domains from Gcn2 and resulting into an N-
terminally truncated Gcn2 with dramatically reduced kinase activi-
ty [184]. Curiously, the sequence of this protease site is present in
mouse and human Gcn2 but not in yeast [184].
A recent study demonstrated that Gcn2 also protects against DNA
virus infections. In a genetic screen, a mouse with a loss-of-function
mutation in Gcn2 (atchoum) was identiﬁed that exhibits a modest
increase in susceptibility to the double-stranded DNA virus mouse-
cytomegalovirus (MCMV), and, contrary to wild type mice, fails to
phosphorylate eIF2α upon viral infection, supporting the idea that
Gcn2 contributes to viral defence against MCMV in vivo [186].
Some DNA viruses have evolved a mechanism to counteract PKR ac-
tivation by ds-RNA that is formed during viral transcription/replication,
which is the expression of eIF2α pseudosubstrates [187–189]. For
example, vaccinia virus protein K3L has homology to the N-terminal
part of eIF2α (eIF2α amino acids 1–88), but the amino acid equivalent
to Ser51 is Lys, making K3L non-phosphorylatable. K3L, and similar
proteins encoded by other viruses, function by competing with eIF2α
for PKR binding. K3L-mediated inhibition of PKR antagonises the host′
s main mechanism that prevents viral propagation by shutting down
the translation machinery. K3L expression in yeast cells showed that
K3L directly interacts with the Gcn2 protein kinase catalytic domain
and impairs Gcn2 activation [190,191]. Even though the overexpression
of Gcn2 in mammalian cells does not seem to hamper the replication
of vaccinia virus, at least under these experimental conditions [96],
the ability of vaccinia virus K3L to directly inhibit Gcn2 in vivo in
mammalian cells has not yet been addressed experimentally.
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Apart from the GAAC, amino acid starvation is also sensed by the
signalling pathway governing the protein kinase Tor (Target of
rapamycin), speciﬁcally by the Tor containing protein complex 1
(TORC1). Active TORC1 promotes protein synthesis e.g., by directly
phosphorylating and activating the ribosomal protein S6 kinase (S6K
in mammals and Sch9 in yeast), and additionally in mammals by
phosphorylating and inhibiting the translational repressor eIF4E-
binding protein 1 (4E-BP1) [192–196]. TORC1 is inactivated by several
nutrient deprivation conditions as well as by the drug rapamycin.
Hence, GAAC and Tor signalling pathways may co-ordinately prevent
the translational machinery from using unnecessary amounts of vital
resources under nutrient limiting conditions.
Cross-talks between GAAC and the TOR signalling pathway were
found in S. cerevisiae. Tor inactivation promotes Gcn2 activation by a
mechanism involving the dephosphorylation of Gcn2 Ser-577 [88,89].
Tor inactivity leads to the dephosphorylation of Tap42, therebyweaken-
ing its association with phosphatases [193]. It has been proposed that
phosphatases (Sit4 and/or PP2A) freed from TAP42, mediate dephos-
phorylation of Gcn2 Ser-577 [88]. This mechanism of Gcn2 stimulation
appears to require tRNAdeacyl, since the gcn2-m2 mutation abolishes
the activation [88,89]. S577A substitution increases Gcn2 afﬁnity to
tRNAdeacyl in vitro, suggesting that Ser-577 dephosphorylation may be
sufﬁcient to allow Gcn2 to bind tRNAsdeacyl in vivo to trigger its activa-
tion [197]. In fact, in vivo the S577A substitution leads to constitutively
increased Gcn2 auto-phosphorylation at Thr882, and increased eIF2α
phosphorylation [47,197].
Curiously, following 30 min rapamycin treatment, some eIF2α
phosphorylation was observed in a gcn1Δ strain, while another
group found that Gcn1 is absolutely required for Gcn2 activation 2
h after rapamycin treatment [87,89]. Supporting the idea that Gcn1
is relevant, growth assays show that rapamycin sensitivity is depen-
dent on Gcn2 as well as Gcn1 [42]. In another study, after 30 min of
rapamycin treatment, strains with a constitutively active TAP42
allele only show 30% reduction in Ser-577 phosphorylation levels
as compared to the wild-type strain (80% reduction), and this level
stays almost constant for up 4 h, while in the wild-type the phos-
phorylation level gradually reverts back to almost the original level
[88]. At 30 min of rapamycin treatment, despite the large differences
in Ser-577 phosphorylation between these strains, their eIF2α phos-
phorylation levels are increased to similar levels. These observations
raise the possibility that a constitutive eIF2α phosphatase becomes
transiently inhibited, or that an alternative pathway transiently
activates Gcn2 that may not require Gcn1 [88].
In addition to the treatment of cells with rapamycin, the inhibition
of Tor by shifting cells to a poor nitrogen source such as GABA (γ-
aminobutyric acid) also activates Gcn2 through a mechanism involving
the Sit4 phosphatase [11]. Shifting cells to GABA medium results in the
accumulation of selected tRNAdeacyl, and GAAC response requires the
Gcn2 m2 residues, pointing to tRNAsdeacyl as the activating ligands for
Gcn2 [11]. Curiously, shifting cells to GABA medium leads to a signiﬁ-
cant increase in tRNAsdeacyl after 60 min but not by 15 min, and yet
eIF2α phosphorylation was already at its maximum level at 15 min. It
was suggested that tRNAsdeacyl and Tor may contribute to Gcn2 activa-
tion at different time frames following exposure to GABA [11].
Other possible links by which the TOR pathway impinges on the
GAAC pathway may be mediated via two other proteins that are each
under the control of TOR and that have been found to be in complex
with Gcn2, Sch9 and Npr1. Puriﬁed Gcn2, as well as the γ subunit of
eIF2, co-precipiate Sch9 from yeast extract [198], but Sch9 does not
phosphorylate Gcn2 Ser-577 [193]. SCH9 deletion leads to constitutive
eIF2α phosphorylation, while strains harbouring the rapamycin-
insensitive Sch92D3E (amino acid substitutions mimicking activated
Sch9) are unable to increase eIF2α phosphorylation in response to
rapamycin treatment [199]. The exact molecular mechanism by whichSch9 regulates eIF2α phosphorylation, and whether this is mediated
via altering Gcn2 activity, remains to be determined.
The yeast protein kinase nitrogen permease reactivator/regulator 1
(Npr1) which controls amino acid permeases, is dephosphorylated
and activated by rapamycin [195,200]. In an attempt to experimentally
determine protein kinase interaction networks in yeast, followed by co-
precipitation experiments, Npr1 was found to be in complexwith Gcn2,
raising the possibility that Npr1 is a novel Gcn2-regulator [201].
These ﬁndings support a model in which both signalling pathways
act synergistically to promote cellular responses to changes in nutrient
availability. The kinase(s) involved in Gcn2 down regulation by phos-
phorylating Ser-577, as well as the conditions leading to its(their) acti-
vation are yet to be determined. In mammals, evidences have not been
reported yet that support a direct activation of Gcn2 by the inhibition of
mammalian (mTOR). We cannot exclude the possibility that mammali-
an Gcn2 contains an amino acid equivalent to yeast Gcn2 Ser-577,
though its identiﬁcation is difﬁcult given the low sequence conservation
around Ser-577. Interestingly, studies in mammals raise the possibility
that Gcn2 contributes to the regulation of the Tor pathway (e.g. [16,
202–204]; it remains to be determined whether the same is true in
yeast.12. Heat shock proteins
In yeast it appears that Gcn2 maturation and accumulation are
reliant on the chaperone protein Hsp82, which alongside its isoform
Hsc82, are orthologues of mammalian Hsp90. These proteins seem to
be similar in function since Hsp90 can rescue the lethality of a hsc82Δ;
hsp82Δ double deletion strain [205]. Mutations in Hsp82 were found
to de-repress Gcn4 translation under amino acid replete conditions,
and for at least one mutant (G313N) it was determined that this effect
is dependent on Gcn2 [205]. This indicates that Hsp82 is required for
maintaining Gcn2 in its repressed state.
Evidence that Hsp82 engages Gcn2 was obtained by showing that
ectopically expressed Flag-tagged Hsp82 interacts with overexpressed
GST–Gcn2. Using a strain expressing a tagged human Hsp90, it was
shown that both the endogenous Gcn2 and an overexpressed GST–
Gcn2 fusion protein interact with Hsp90 in co-immunoprecipitation
assays. Gcn2–Hsp90 interaction appears to be mediated by a fragment
encompassing mainly the Gcn2 kinase domain (residues 507–1092),
and Gcn2 kinase activity is not necessary for this interaction [205].
Unfortunately, native Gcn2–Hsp82 interaction has not been reported
so far [38]. Interestingly, the amount of in vivo Gcn2–Hsp90 interaction
does not change when the cells are starved of amino acids (though data
were not shown), nor does it change much when Hsp82 harbours a
mutation (G313N) that results in Gcn2 activation [205]. It is possible
that in these experiments the overexpression of Gcn2may havemasked
subtle changes in Gcn2–Hsp90/82 interaction. Hsp82 mutations may
weaken the Gcn2–Hsp90 interaction, still allowing Gcn2 maturation
but promoting the release of functionally active Gcn2 even in the
absence of any trigger, or promoting the release by the low levels of
tRNAdeacyl present under replete conditions [38]. The authors propose
a model in which matured Gcn2 remains bound to Hsp82/90, and
under amino acid starvation the binding of tRNAdeacyl to Gcn2 releases
it from Hsp82/90, to then allow for Gcn2 activation. Because of the
known intrinsic activity of puriﬁed Gcn2, it was not possible to deter-
mine whether the binding of tRNAdeacyl would trigger the dissociation
of Hsp90 from Gcn2. Gcn2 synthesised in rabbit reticulocyte lysates in
the presence of the Hsp90 inhibitor, geldanamycin, is inactive in auto-
phosphorylation assays. In parallel, inhibition of Hsp90 also results in
stronger interaction of Hsp90 with Gcn2. Together these data indicate
that Hsp90 plays an essential role in Gcn2 maturation and for it to
become an active kinase. Stronger inhibition of Hsp90 in vitro or inhibi-
tion of Hsp82 in vivo resulted in decreased amounts of Gcn2, indicating
that this chaperone is required for stability of Gcn2 as well.
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binding [206]. Interestingly, yeast cells with mutated co-chaperone
Cdc37 (p50 in mammals), or cells lacking co-chaperone Sba1 (p23) or
Sti1/HOP (p60), are not capable of efﬁciently overcoming amino acid
starvation. The possible mechanism of these co-chaperones in contrib-
uting to the maturation of Gcn2 remains to be studied.
Chaperones such as Hsp90 have been proposed to play a major role
in promoting protein complex assembly in addition to folding [207],
raising the possibility that Hsp90 may be involved in assembling
complexes containing Gcn2 and its effector protein Gcn1, and possibly
also the Gcn2-inhibitor eEF1A [153], to ensure that de novo synthesised
Gcn2 does not become accidentally activated.
13. Snf1
The highly conserved AMP-activated serine/threonine protein
kinase, AMPK in mammals or Snf1 in yeast, is part of a signalling path-
way that ensures homeostasis of available chemical energy in the
form of ATP [208,209]. It is activatedwhen the AMP/ATP ratio increases,
to then switch off energy-consuming anabolic pathways while turning
on ATP-producing pathways. The so far best understood function of
Snf1 is its activation under glucose starvation, or in presence of non-
preferred carbon sources, in order to induce expression of genes that
allow the utilisation of alternative carbon sources [210].
Snf1 was found to be also activated by amino acid starvation, and a
physical and functional link between the Snf1/carbon signalling path-
way and GAAC was uncovered [47]. In response to His starvation,
Gcn2 auto-phosphorylation and eIF2α phosphorylation are increased
in amanner that is (mostly) dependent on Snf1 kinase activity. This cor-
relates with Snf1 phosphorylation at its Thr-210, suggesting that Snf1
becomes stimulated under His starvation, and this again is shown to
be required for full Gcn2 activation. Snf1 and Gcn2 interact with each
other in vivo as judged via co-immunoprecipitation experiments, how-
ever, no evidence was found for Snf1 directly phosphorylating Gcn2.
Reg1 is a negative regulator of Snf1 [210], and under amino acid
starvation REG1 deletion leads to increased phosphorylation of Gcn2
Thr-822 and eIF2α, in a manner that is dependent on Snf1. This indi-
cates that under starvation, Reg1 dampens Snf1 stimulatory function
on Gcn2. Under amino acid-replete conditions reg1Δ cells show
decreased eIF2α phosphorylation but unaltered basal Gcn2 Thr-882
auto-phosphorylation levels, in a manner dependent on Snf1. Thus, it
appears that in unstarved reg1Δ strains, the resultant increased activity
of Snf1 somehow may stimulate an eIF2α phosphatase.
When cells are shifted from glucose to a non-preferred carbon
source (galactose), Snf1 is required to maintain normal eIF2α phos-
phorylation levels, but this does not involve Gcn2 activation and instead
involves regulation of eIF2α phosphatases [47]. Interestingly, in
contrast to that, when cells starve for a carbon source the response
mechanism appears to be different, since in this situation eIF2α phos-
phorylation is increased in a Gcn2-dependent manner (Section 4) [77].
14. RACK1/Asc1
Mammalian Receptor for Activated C-Kinase, Rack1, or its
S. cerevisiae orthologue Asc1 (formerly called Cpc2), is a highly
conserved protein consisting of 7 tryptophan-aspartate (WD) repeats.
This protein has been shown to function as a scaffold for proteins in
various signal transduction pathways, thereby allowing the localised
orchestration of signalling events, and accordingly, it plays essential
roles in regulating a wide array of biological processes [211].
Asc1 affects Gcn2 function in addition to events downstream of
Gcn2. In S. cerevisiae, Asc1 contributes to the docking of translation ini-
tiation factors to the ribosome during general translation initiation,
thereby blunting the inhibitory action of the uORFs in the GCN4mRNA
leader [212]. Under amino acid starvation, ASC1 deletion suppresses
the growth defect of a gcn2Δ strain, and this is not due to simultaneousdeletion of the snoRNA U24 located in the ASC1 intron, again suggesting
that Asc1 negatively regulates GAAC in S. cerevisiae [213]. In addition,
ASC1 deletion leads to increased eIF2α phosphorylation under replete
conditions; although unlikely, it remains to be veriﬁed that this is not
mediated by U24 [214].
Curiously, recent studies have revealed that the Rack1 homologue in
Schizosaccharomyces pombe, Cpc2, actually promotes, rather than
represses, the GAAC response [215]. Cpc2 is required for starvation-
induced Gcn2 auto-phosphorylation, eIF2α phosphorylation and
expression of amino acid biosynthesis genes [215]. It was conﬁrmed
that impaired Gcn2 activation is due to CPC2 deletion and not due to
lack of the snoU24b gene located in the CPC2 intron [215]. Although
Cpc2 appears to have an almost opposite effect in S. pombe as compared
to S. cerevisiae, Gcn2 auto-phosphorylation in cpc2 mutants can be
restored by introducing Asc1 or mammalian RACK1 [215]. Thus, the
apparent difference in regulation is not due to functional differences
in the Cpc2 homologs themselves, but is more likely the result of differ-
ences in other components that regulate the GAAC system. Regulatory
differences may be due to the fact that Gcn2 is the sole eIF2α kinase
in S. cerevisiae, whereas Gcn2 is one of three eIF2α kinases in S. pombe
[215]. It will be interesting to investigate how RACK1 controls Gcn2 in
mammals.
Asc1 and RACK1 were shown to be a stochiometric ribosomal
component [216]. S. pombe Gcn2 also contacts the ribosome as found
for the S. cerevisiae counterpart [98,215], however, Cpc2 is not required
for Gcn2 dimerisation or Gcn2–ribosome interaction, and genetic
studies showed that ribosome-free Cpc2 retains its ability to regulate
Gcn2 [215]. The authors suggest that Cpc2 modulates the activity of a
Gcn2 regulatory protein, or Cpc2 may be involved in transmitting an
activating signal to Gcn2 [215]. It is unknown whether Cpc2 and Gcn2
interact with each other, and a physical interaction between Asc1 and
Gcn2 was not found [214], though one cannot exclude the possibility
that it is too transient to be detected.
Clearly the role of Asc1/Cpc2/RACK1 in the regulation the GAAC
response requires further investigation. Rack1 and its orthologues
have also been shown to play signiﬁcant roles in transporting proteins
around the cell and ensuring sub-compartmental protein localisation,
in addition to controlling the activity of proteins [211]. Thus, it is plausi-
ble that Asc1/Cpc2/RACK1 could spatially regulate protein interactions
with or upon the ribosome and thus spatially regulate Gcn2.
15. PI3K pathway
The PI3K signalling pathway is involved in cell proliferation and
has neuroprotective functions [217–219]. This pathway is stimulated
by growth factors or insulin, and leads to the activation of
phosphoinositide-3 kinases (PI3Ks) which phosphorylate inositol
lipids in membranes to generate phosphoinositide 3,4,5-triphos-
phates (PIP3). This stimulates the phosphoinositide-dependent
kinase 1 (PDK1) which then phosphorylates and activates Akt1.
Akt1 is a kinase that in turn regulates many proteins, such as
inhibiting glycogen synthase kinase 3β (GSK-3β), to then trigger
further downstream events.
The yeast orthologue of mammalian PDK1, Pkh1, interacts with
Gcn2 in vitro and in vivo [198]. Interestingly, in in vitro kinase assays
Pkh1 phosphorylates Gcn2, even thoughGcn2 does not contain a typical
Pkh1 phosphorylation site [198]. However, in yeast, inactivation of all 3
orthologues of mammalian Pdk1 has no signiﬁcant effect on the
phosphorylation of eIF2α at Ser-51 or on GCN4 translation in response
to amino acid starvation [198]. This would suggest that either there is
sufﬁcient redundancy in the system so that another protein can subs-
titute for the loss of Pkh1, or that it might regulate Gcn2 activity in
response to conditions other than amino acid starvation.
Recently, itwasdescribed that Gcn2 activity is regulated by the PI3K/
Akt/GSK-β pathway, both in neurons and in ﬁbroblast cells [220].
Pharmacological inhibition of PI3K downregulates Gcn2 activity, as
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tion, and ATF4 levels, while intracellular delivery of PIP3, or transient
overexpression of the constitutively active PI3K p110*, have the opposite
effect in that they lead to increased eIF2α phosphorylation and ATF4 ex-
pression. PI3K activation leads to the inhibitory phosphorylation of GSK-
3β, and as expected, inhibiting GSK-3β results in increased levels of Gcn2
auto-phosphorylation, eIF2α phosphorylation and ATF4. Furthermore,
these effects were shown to be speciﬁc since in Gcn2−/− cells, inhibition
of GSK-3β did not affect eIF2α phosphorylation or ATF4 expression
relative to control non-treated cells. Fibroblasts lacking each of the
other three eIF2α kinases maintained the ATF4 response to either the
PI3K inhibitor or to the GSK3 inhibitor, showing that the effect is directed
to Gcn2. It is not known yet how GSK3βmodulates Gcn2 activity.
It is also worth noting that eIF2α phosphorylation can activate the
PI3K pathway [221]. Most likely this occurs indirectly as a result of the
reduced translation of some protein(s) that normally represses PI3K
signalling [221]. This raises the possibility of a feedback loop, mediating
cross talks between the GAAC and PI3K pathways.
16. Conclusion
As highlighted throughout this review, there are still several impor-
tant gaps that need to be ﬁlled on themechanisms of howGcn2 receives
its activating signal. For example, it is still far from being understood
how immediate players, such as Gcn1 and the ribosome, contribute to
the exquisite in vivo responsiveness of this kinase. Many other mole-
cules have been uncovered, and new molecules are constantly being
added, that directly or indirectly modulate Gcn2 activation. It is likely
that this regulatory circuitry is even more diverse in mammalian cells
in order to provide further avenues for controlling Gcn2 function in re-
sponse to the speciﬁc needs of different cell types. Indeed, large-scale
studies suggest that many additional proteins may participate in the
regulation of Gcn2, either by interacting directly with it, with Gcn1 or
with the other proteins described here, or by stimulating Gcn2 via indi-
rect mechanisms. New cross-talks between the GAAC and other central
signalling pathways are being continuously unravelled (e.g. PI3K and
Tor pathways). Understanding these links is paramount, as the last
few years have seen an impressive accumulation of experimental
evidence implicating Gcn2 in previously unforeseen physiological path-
ways and diseases. For example, Gcn2 has been implicated with cancer,
andwith the efﬁcacy of anticancer drugs. Thus, it is fundamental to gain
a detailed understanding of the function of each Gcn2 regulator, as well
as of the comprehensive Gcn2-regulatory network, that continuously
adjusts Gcn2 activity and activation. Simultaneously, this will allow
the pinpointing of new drug targets for correcting and preventing
Gcn2-associated diseases/disorders.
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